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ABSTRACT

MECHANISMS OF TELOMERE REPAIR SYNTHESIS
Robert Lawrence Dilley
Roger A. Greenberg, M.D., Ph.D.

Homology-directed DNA repair (HDR) necessitates templated DNA synthesis to repair
double-strand breaks (DSBs), replicative lesions, and telomeres. Alternative lengthening of
telomeres (ALT) is a clinically relevant model of HDR responsible for telomere maintenance in
~10-15% of human cancers. However, the mechanisms of mammalian HDR synthesis at
telomeres or elsewhere in the genome were largely unknown. Here, we discovered that telomere
DSBs elicit robust templated synthesis capable of generating long nascent telomeres, a process
we named break-induced telomere synthesis (BITS). BITS and spontaneous telomere repair
synthesis proceed through an alternative form of HDR independent of RAD51 that requires DNA
polymerase , including its POLD3 subunit. RAD52 controls spontaneous telomere repair
synthesis but is dispensable for BITS, suggesting lesion specific pathway requirements.
Additionally, telomere maintenance is disrupted in ALT cells deficient in POLD3 or RAD52,
demonstrating that telomere repair synthesis underlies ALT. While POLD3 emerged as a central
mediator of numerous DNA repair synthesis processes, its protein interaction network was largely
unknown. To address this, we purified the POLD3 replication complex and uncovered novel
interactions predicted to impact replication and repair. Taken together, this thesis provides some
of the first mechanistic insights into mammalian HDR synthesis as well as a framework for
continued studies of DNA repair synthesis and telomere maintenance.
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CHAPTER 1: INTRODUCTION

Part of this chapter is adapted from
Dilley RL, Greenberg RA. ALTernative Telomere Maintenance and Cancer. Trends in Cancer
2015;1(2):145-156. doi:10.1016/j.trecan.2015.07.007. (Dilley and Greenberg, 2015)

I. DNA damage and repair
Links between DNA damage and cancer
The DNA in our cells is constantly damaged by endogenous and environmental sources,
posing threats to faithful passage of genetic information and survival (Ciccia and Elledge, 2010;
Hoeijmakers, 2009; Lindahl, 1993; Vilenchik and Knudson, 2000; 2003). Therefore, eukaryotic
cells have evolved DNA damage response (DDR) and repair mechanisms to cope with these
insults (Ciccia and Elledge, 2010). Early insights into the connections between DNA integrity and
cell fitness came in the early 20th century, when changes in chromosome distribution and
structure were shown to correlate with genetic and phenotypic variation (Boveri, 2008; Jeggo et
al., 2016; Muller, 1927; 1928). Following the discovery of the structure of DNA, direct evidence of
chemical-induced changes in DNA and their links to cancer emerged, providing an explanation for
the high incidence of scrotal cancer among chimney sweeps documented in the 18th century
(Brookes and Lawley, 1960; 1961; 1964; Franklin and Gosling, 1953; Pott, 1993; Watson and
Crick, 1953). While the impact of DNA damage on cell viability and transformation was
increasingly being recognized, the first evidence of a DNA repair deficiency resulting in cancer
was discovered in the genetic syndrome xeroderma pigmentosum (XP). Cells with XP were
shown to be unable to repair DNA damage due to ultraviolet light, resulting in a dramatically
increased risk of skin cancer (Cleaver, 1968). Later studies identified DNA repair deficiencies in
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several other cancer predisposition syndromes, including Bloom, Werner, and Fanconi anemia,
as well as hereditary breast and ovarian cancers (Jeggo et al., 2016).
DNA damage and altered DNA repair can ultimately lead to genome instability, which is
now an established hallmark of human cancer (Hanahan and Weinberg, 2011). Current models of
cancer development propose that oncogene-induced replication stress, which leads to DNA
damage, as well as downregulation of the DDR both contribute to cancer initiation and
progression. Indeed, DDR genes are frequently mutated in many cancer types, providing novel
disease insights as well as therapeutic opportunities (Pearl et al., 2015). It is increasingly being
recognized that accumulation of DNA damage and the activity of the DDR also have implications
for aging and other human diseases (Hoeijmakers, 2009). In addition to responding to
spontaneous damage, DDR pathways are central to a diverse set of programmed cellular
processes including telomere maintenance, antibody diversity, and meiotic recombination. As
such, it is expected that continued exploration of the DDR will provide important insights into
many cellular activities and their relevance to disease.

The DNA damage response
The DDR is comprised of an intricate network of proteins activated in a spatiotemporal
manner by diverse DNA stimuli (Ciccia and Elledge, 2010). These include chemical changes to
DNA such as base alterations, single-strand breaks (SSBs), and double-strand breaks (DSBs), as
well as perturbations to the replication fork during genome duplication. Like other signaling
cascades, the DDR begins with a recognition event followed by the sequential activation of
mediators and effectors. Sensor proteins localize rapidly to DNA lesions, with SSBs recognized
by poly(ADP-ribose) polymerase (PARP) and DSBs recognized by PARP, Ku70/Ku80, and
MRE11-RAD50-NBS1 (MRN) (Caldecott, 2008; Mahaney et al., 2009; Schreiber et al., 2006;
Williams et al., 2007). Replication protein A (RPA) acts as a sensor of single-stranded DNA
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(ssDNA) present at stalled replication forks and processed DNA breaks (Cimprich and Cortez,
2008). These sensors then activate mediator proteins of the phosphatidylinositol 3-kinase-like
protein kinase (PIKKs) family (ATM, ATR, and DNA-PK) or directly perform a mediator function in
the case of PARP (Schreiber et al., 2006; Zhou and Elledge, 2000). Signaling through these
proteins is at the core of the DDR, coordinating effectors of DNA repair, cell cycle progression,
cell death, and many other intersecting cellular processes.
Since cells accumulate thousands of DNA lesions per day, it is crucial to directly repair
damage as it arises (Hoeijmakers, 2009; Vilenchik and Knudson, 2000; 2003). While PARP and
PIKK signaling can be activated by a broad set of stimuli, distinct repair pathways have evolved to
fix specific lesions. A simplified categorization of these pathways is as follows. Mismatched DNA
bases are repaired by the exonuclease activity of DNA polymerases during DNA synthesis or by
the mismatch repair (MMR) machinery (Jiricny, 2013). Small chemical changes to bases are
corrected by base-excision repair (BER), whereas bulkier base lesions are repaired by
nucleotide-excision repair (NER) which both involve nuclease activity and fill-in synthesis (Krokan
and Bjørås, 2013; Schärer, 2013). SSBs are fixed by the SSB repair pathway which also involves
gap filling and ligation (Caldecott, 2008). DSBs are repaired either by direct ligation of the broken
ends during non-homologous end joining (NHEJ) or by homology-directed repair (HDR)
mechanisms whereby a homologous sequence is used as a template (Chiruvella et al., 2013;
Jasin and Rothstein, 2013). Additional pathways exist for the repair of replication fork lesions and
interstrand crosslinks (ICLs) (Deans and West, 2011; Yeeles et al., 2013). The convergence of
multiple repair pathways on DSBs and replicative lesions necessitates spatiotemporal and
context specific regulation of pathway choice and activation. Indeed, disrupting the balance of
these pathways can lead to genome instability (Chapman et al., 2012).

II. Homology-directed repair
HDR family of repair pathways
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DNA DSBs are among the most toxic lesions faced by cells, requiring multiple pathways
for timely and accurate repair. While NHEJ results in direct ligation of broken ends, HDR
pathways use a homologous donor sequence as a template, thereby restricting repair to an
appropriate site in the context of replication or multiple simultaneous breaks. HDR pathways can
be grouped into three broad categories: gene conversion (GC), break-induced replication (BIR),
and single-strand annealing (SSA) (Jasin and Rothstein, 2013; Mehta and Haber, 2014). A
distinguishing feature of HDR is an initial 5’-to-3’ resection event which generates 3’ overhangs.
These overhangs are then used for homology search, pairing, and subsequent priming of
templated DNA synthesis. Finally, repair intermediates are resolved by a set of helicases,
nucleases, and ligases into crossover or non-crossover products. While GC and BIR share
several mechanistic similarities, SSA is a simpler form of repair where repeats exposed during
resection are directly annealed together, deleting the intervening sequences. Aside from SSA,
HDR was historically believed to be a high-fidelity process compared to NHEJ, which often
generates small insertions and deletions. However, recent evidence suggests a high mutation
rate and genome instability driven by certain forms of HDR (Deem et al., 2011; Hicks et al., 2010;
Malkova and Haber, 2012; Strathern et al., 1995; Yang et al., 2008). Nevertheless, much of HDR
is critical for genome maintenance and cell viability. Indeed, disruption of core HDR proteins,
such as BRCA1/2 can lead to embryonic lethality or tumorigenesis due at least in part to a shift
toward toxic end-joining processes (Bunting et al., 2010; Evers and Jonkers, 2006).
HDR has commonly been studied using -irradiation and site-specific nucleases, which
create two-ended DSBs that are repaired by GC or NHEJ (Jasin and Rothstein, 2013; Mehta and
Haber, 2014). However, the majority of endogenous DSBs and HDR are thought to occur due to
replication of the genome (Mehta and Haber, 2014; Vilenchik and Knudson, 2003). Such
replicative lesions, including stalled forks and one-ended DSBs from fork collapse, are repaired
by an alternative set of HDR mechanisms, including BIR (Anand et al., 2013; Li and Heyer, 2008;
Verma and Greenberg, 2016). Notably, BIR pathways are implicated not only in repair of
replication forks, but also in a subset of telomere maintenance, highlighting an expected
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physiologic relevance across different genomic contexts and disease processes (Anand et al.,
2013).

Break-induced replication
BIR is an evolutionarily conserved set of pathways used to repair replication fork lesions,
telomeres, and one-ended DSBs, being reported in bacteria and bacteriophages, budding yeast,
and more recently in mammalian cells (Anand et al., 2013). Our current understanding of
eukaryotic BIR has largely come from studies in S. cerevisiae using chromosome fragmentation
assays and site-specific nucleases that generate DSBs where only one end shares homology
with a donor sequence. Early studies identified BIR as a recombination process whereby
establishment of a replication fork allowed for copying of sequences distal to the break-site all the
way to the end of the chromosome (Bosco and Haber, 1998; Malkova et al., 1996; Morrow et al.,
1997). The initial steps of BIR are similar to those reported for GC, specifically 5’-to-3’ end
resection, RPA binding, and generation of a Rad51 nucleofilament used for homology search
(Davis and Symington, 2004; Jain et al., 2009; Krogh and Symington, 2004). However, BIR differs
considerably in the subsequent steps of templated DNA synthesis. While GC requires the action
of a subset of replicative polymerases, BIR involves a larger repertoire of replication factors
including the non-essential subunit of DNA polymerase  (Pol ), Pol32 (Holmes and Haber,
1999; Lydeard et al., 2007; 2010; Wang et al., 2004). Synthesis during BIR also differs from GC
and S-phase replication due to its migrating bubble structure which leads to conservative
inheritance of nascent DNA and its increased mutagenic potential (Deem et al., 2011; Saini et al.,
2013; Smith et al., 2007; Wilson et al., 2013).
Although more than 95% of BIR and GC events in yeast are reported to be Rad51dependent, a surprisingly efficient subset of non-canonical Rad51-independent BIR also
facilitates repair (Bai and Symington, 1996; Davis and Symington, 2004; Malkova et al., 1996).
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This Rad51-independent BIR needs less homology than the Rad51-mediated pathway and
genetically requires Rad52, MRX, Rad59, and Rdh54 (Bosco and Haber, 1998; Cortés-Ledesma
et al., 2007; Ira and Haber, 2002; Signon et al., 2001). It was suggested that Rad51-independent
events may occur between short repeats by annealing mechanisms (Bärtsch et al., 2000; Ira and
Haber, 2002).
The relevance of Rad51-dependent and –independent mechanisms of BIR is supported
by recombination based telomere maintenance in yeast (McEachern and Haber, 2006). This
phenomenon was first documented in yeast cells lacking a functional telomerase, where a subset
of survivors emerged that lengthened their telomeres in a Rad52-dependent manner (Lundblad
and Blackburn, 1993). Further studies defined two types of survivors (Chen et al., 2001; Huang et
al., 2001; Johnson et al., 2001; Le et al., 1999; Lundblad and Blackburn, 1993; Teng and Zakian,
1999; Teng et al., 2000; Tsukamoto et al., 2001). Type I survivors lengthen their telomeres by
amplification of Y’ subtelomeric sequences in a manner dependent on Rad52, Rad51, Rad55/57,
and Rad54. In contrast, Type II survivors generate very long telomeres through amplification of
the telomeric TG1-3 repeats in a manner independent of Rad51 but requiring Rad52, MRX, Rad59,
and Sgs1. Since telomeres resemble a one-ended DSB, it was hypothesized that these survivor
pathways proceed through a BIR mechanism similar to that described for internal one-ended
DSBs. Strong evidence supporting this idea came from the discovery that nuclease-induced BIR
and both survivor pathways require Pol32, whereas GC does not (Lydeard et al., 2007).
Telomere maintenance in the absence of telomerase has also been documented in a
subset of immortalized cell lines and ~15% of human cancers (Bryan et al., 1997; 1995; Cesare
and Reddel, 2010; Dilley and Greenberg, 2015). Activation of this process, termed alternative
lengthening of telomeres (ALT), provides a clinically relevant and tractable system to study
human BIR-like pathways which are hypothesized to underlie ALT. Although the mechanisms of
ALT remain poorly understood, studies point to an HDR-based process (Dunham et al., 2000;
Yeager et al., 1999). Recent work has also revealed evidence for mammalian BIR-like pathways
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that respond to replication stress. Overexpression of Cyclin E, which leads to massive replication
stress, resulted in DNA repair synthesis and genomic duplications that required POLD3, the
mammalian homolog of Pol32 (Costantino et al., 2014). In another study, chemically-induced
replication stress led to POLD3-dependent DNA repair synthesis in mitosis that promoted
genome stability (Minocherhomji et al., 2015). Other examples of replication-associated repair
with potential connections to BIR include long-tract gene conversion after fork stalling and forkrestart in the absence of a DSB (Miyabe et al., 2015; Willis et al., 2014). Additionally,
microhomology-mediated BIR (MMBIR) is a replication-dependent mechanism of fork repair that
is proposed to generate complex chromosomal rearrangements and copy-number variations
through template switching (Carvalho and Lupski, 2016; Hastings et al., 2009a; 2009b; Lee et al.,
2007; Payen et al., 2008; Sakofsky et al., 2015; Zhang et al., 2015; 2009). Based on studies in
yeast, many of these mammalian BIR pathways are also hypothesized to proceed in part through
alternative mechanisms independent of RAD51 (Verma and Greenberg, 2016). While it is
becoming clear that BIR-like pathways are involved in mammalian DNA repair, further studies are
needed to understand the mechanistic details and connections between these replication fork
repair pathways and ALT, as well as the regulation of pathway choice. It will also be important to
determine the contribution of these pathways to genome stability or instability and how they may
be coopted or subverted in human diseases such as cancer.

III. Alternative lengthening of telomeres
Telomere maintenance in cancer
The idea that chromosome ends require protection came from studies in the first half of
the 20th century (McClintock, 1938). Work over the past 80 years has elaborated how protection
is achieved by specialized nucleoprotein structures called telomeres. Composed of DNA repeats
(5’-TTAGGG-3’) and the shelterin protein complex which cooperatively prevent recognition as a
DSB, telomere structure is essential for genome stability (O'Sullivan and Karlseder, 2010; Palm
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and de Lange, 2008). Telomeres shorten with each cell cycle in somatic cells, which generally
lack a telomere maintenance mechanism (TMM), eventually leading to senescence or crisis
depending on the degree of telomere dysfunction. Therefore, to bypass such roadblocks to
proliferation, continuously-dividing cells need to find a means to maintain their telomeres. Indeed,
it is now well accepted that cancers must achieve a state of replicative immortality to form robust
tumors, and that activation of a TMM is central to this process (Hanahan and Weinberg, 2011).
Most human cancers reactivate the reverse transcriptase telomerase (Artandi and DePinho,
2010). However, a significant proportion (~5–15%) utilize an HDR-based TMM, known as
alternative lengthening of telomeres (ALT) (Cesare and Reddel, 2010; Draskovic and LondoñoVallejo, 2013).
ALT was originally discovered in immortalized cell lines and was subsequently shown to
occur in human tumors (Bryan et al., 1995; 1997). The first definitive evidence for a homologydirected process between telomeres on different chromosomes came from a study showing that a
telomere tag could be copied to multiple telomeres only in telomerase-negative cells, indicating
that ALT occurs via HDR (Dunham et al., 2000). Indeed, a requirement for HDR was predicted
from studies in yeast definitively showing a Rad52 recombination-dependent telomere
maintenance and survival of telomerase null yeast (Chen et al., 2001; Le et al., 1999; Lundblad
and Blackburn, 1993; Teng and Zakian, 1999; Teng et al., 2000). In the past two decades,
tremendous progress has been made in characterizing the ALT phenotype. It is now widely
accepted that ALT cells have highly heterogeneous, fluctuating telomere lengths (Bryan et al.,
1995; Murnane et al., 1994), high levels of telomere sister chromatid exchanges (t-SCEs)
(Londoño-Vallejo et al., 2004), abundant extrachromosomal telomeric repeat DNA (ECTR)
(Cesare and Griffith, 2004; Henson et al., 2009; Nabetani and Ishikawa, 2009), and a specialized
telomeric DNA nuclear structure termed ALT-associated promyelocytic leukemia (PML) bodies
(APBs) containing many DDR and repair proteins (Yeager et al., 1999). Such characteristics have
afforded opportunities to investigate the mechanisms of ALT, the prevalence and prognostic
consequences of ALT in cancer patients, and the potential for targeted therapies.
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Spectrum and characteristics of ALT-positive cancers
The recent application of tests for ALT phenotypic markers, including telomere length
heterogeneity, APBs, and ECTR, to large sets of human tumor samples has begun to reveal the
spectrum of cancers that utilize ALT (Dilley and Greenberg, 2015). The most comprehensive
study to date analyzed APBs in over 6000 tumor specimens from a wide range of cancer
subtypes and found ALT activity in a little under 4% of the samples (Heaphy et al., 2011b). When
combined with other more-focused studies, the prevalence of ALT activity increases to 11% of all
tumors (Dilley and Greenberg, 2015). However, there is no universal definition for ALT activity,
and most studies of patient samples investigate only one or two of the phenotypic markers. In
addition, tumors can have intratumoral heterogeneity in telomere lengths and TMM activity, with
ALT and telomerase functioning in different cells within the same tumor (Gocha et al., 2013;
Pezzolo et al., 2015). Therefore, it is possible that the prevalence of ALT may be over- or underrepresented by the markers currently used.
It is clear that some tumor types commonly use ALT to maintain their telomeres.
Specifically, ALT activity is most prevalent in cancers arising from mesenchymal tissues (Henson
and Reddel, 2010), including bone (62%), soft tissues (32%), neuroendocrine systems (40%),
peripheral nervous system (PNS; 23%), and the central nervous system (CNS; 15%). ALT has
also been documented in a small percentage of epithelial cancers (Henson and Reddel, 2010).
The biological underpinnings and significance of this mesenchymal enrichment remain unknown.
Interestingly, ALT can be suppressed in hybrids of ALT cells with normal cells and telomerasepositive cells, suggesting the existence of an ALT repressor (Perrem et al., 1999). Whether loss
of such a repressor is more prevalent in mesenchymal cells is unknown. Biallelic loss of function
mutations of chromatin remodeler ATRX (alpha-thalassemia/mental retardation syndrome Xlinked) and the histone chaperone DAXX (death domain associated protein) are strongly
associated with ALT and thus could represent candidates for the putative ALT suppressor.
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However, in some contexts telomerase can be suppressed by hybrids with ALT cells, indicating a
more complex genetic relationship (Katoh et al., 1998).
Early studies revealed a preponderance of p53 (tumor protein p53/TP53) inactivation in
ALT cell lines and tumors (Bryan et al., 1997; Chen et al., 2006). It has been postulated that
elimination of p53 is important for the preservation of high levels of telomeric DNA-damage
signals and chromosomal instability commonly seen in ALT-positive cells (Cesare et al., 2009;
Lovejoy et al., 2012). Although relevant, p53 alterations are prevalent across a wide range of
human cancers and are not specific to ALT (Olivier et al., 2010). By contrast, recently identified
somatic alterations in ATRX and DAXX appear to be common in, and specific to, ALT-positive
tumors, as first shown in pancreatic neuroendocrine tumors (Heaphy et al., 2011a; Lovejoy et al.,
2012). In another study, inactivating mutations in ATRX, DAXX, and neomorphic, gain of function
H3.3 (H3 histone, family 3) missense mutations that globally disrupt histone methylation were
identified in 44% of pediatric glioblastomas and were shown to correlate with ALT activity
(Schwartzentruber et al., 2012). ATRX, DAXX, and H3.3 mutations were often mutually exclusive,
suggesting epistasis. Mutations in the canonical histone H3.1 were also identified in pediatric
brain tumors, albeit at a lower frequency (12%) (Wu et al., 2012). Interestingly, ATRX and DAXX
have been reported to participate in depositing H3.3 onto telomeric chromatin, providing a
biological rationale for these genetic observations. Although alterations in chromatin modifications
appear to be a characteristic of ALT cells, the exact roles of ATRX, DAXX, and H3.3 in the
pathogenesis of ALT remain a topic of intense study, particularly because ATRX mutations are
common in primary cells that achieve immortalization in culture via ALT (Lovejoy et al., 2012).
Alterations in such chromatin factors may create an environment permissive for HDR at
telomeres. For example, ATRX depletion alters cell cycle regulation of the long-noncoding RNA
telomeric repeat-containing RNA (TERRA) and RPA at ALT telomeres, but does not enhance all
ALT characteristics (Eid et al., 2015; Episkopou et al., 2014; Flynn et al., 2015; Lovejoy et al.,
2012). Regardless, the enrichment of some mutations in ALT-positive tumors may provide a
useful diagnostic or prognostic tool.
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Recent insights into the mechanism of ALT
Despite progress in characterizing ALT, we are only beginning to uncover the permissive
events and mechanistic details that lead to productive telomere elongation in this TMM. Several
recent lines of evidence have converged on the importance of the telomeric chromatin status in
ALT (O'Sullivan and Almouzni, 2014). In general, somatic mutations in the chromatin factors
ATRX, DAXX, and H3.3 are enriched in ALT-positive tumors (Heaphy et al., 2011a;
Schwartzentruber et al., 2012), disruption of the histone chaperone ASF1a/b (alternative splicing
factor; SRSF1/2) paralogs can lead to induction of ALT activity (O'Sullivan et al., 2014), and
decreased nucleosomal density and altered histone marks are coupled with increased expression
of TERRA at ALT telomeres (Episkopou et al., 2014). It is likely that a permissive environment for
telomere HDR emerges from these chromatin alterations because such associations are seen to
promote HDR elsewhere (Aymard et al., 2014; Tang et al., 2013). However, it is also possible that
replication stress due to altered histone dynamics and resultant fork stalling may facilitate
recombination at ALT telomeres.
A recent study identified telomeric RNA–DNA hybrids as regulators of the
recombinogenic potential of ALT telomeres (Arora et al., 2014). Despite evidence that telomeric
DNA could be transcribed into TERRA, and that ALT cells displayed high levels of TERRA
species, its role in ALT was unclear (Arora et al., 2014; Azzalin and Lingner, 2015; Azzalin et al.,
2007; Episkopou et al., 2014; Lovejoy et al., 2012). It is now surmised that TERRA has functional
consequences for ALT cells through the creation of RNA–DNA hybrids (R-loops) that occur from
base-pairing of TERRA with complementary regions of telomere DNA (Arora et al., 2014). The
RNA–DNA hybrid endonuclease RNase H1 degrades TERRA–DNA R-loops at telomeres.
Depletion of RNase H1 leads to an increase in recombinogenic potential with rapid telomere
excision, whereas its overexpression weakens recombination and leads to gradual telomere
shortening. These results are enticing given the mounting evidence that R-loops can have
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important regulatory roles as well as be a source of genomic instability (Aguilera and GarcíaMuse, 2012; Bhatia et al., 2014). In light of these findings, it becomes evident that ALT telomeres
must require a balance of pro- and anti-recombinogenic signals to maintain a beneficial cellular
state.
Two studies have shown the role of TERRA in regulating competition between ss
telomeric DNA-binding proteins (Flynn et al., 2015; 2011). Specifically, TERRA inhibits the
ribonucleoprotein hnRNPA1 from displacing the ssDNA-binding protein RPA on telomeres during
S-phase (Flynn et al., 2011). Decreasing TERRA levels in G2 can then facilitate replacement of
RPA with POT1 (protection of telomeres 1), a member of the shelterin complex that specifically
recognizes ss telomere DNA. Interestingly, in ALT cells, dysregulated expression leads to
persistent TERRA expression through G2 and RPA retention at telomeres (Flynn et al., 2015).
Because RPA is important for the initiation of HDR, retained RPA is hypothesized to promote
recombination and ALT activity. Furthermore, RPA has been identified in a subset of APBs in ALT
cells (Draskovic et al., 2009), suggesting it is indeed a part of the ALT repertoire. One function of
RPA is to activate the ATR (ataxia telangiectasia and Rad3-related protein) kinase (Cimprich and
Cortez, 2008). Strikingly, ATR inhibitors were shown to selectively kill ALT-positive cell lines as
compared to telomerase-positive lines (Flynn et al., 2015). While this requires further validation, it
may be that ALT cells have higher levels of replication stress at telomeres, thus creating an
increased reliance on ATR.
While we are rapidly gaining an appreciation of the cellular context in which ALT is
favored, and of the pathways that regulate recombinogenic potential, relatively few studies have
been conducted that detail the precise initiating stimuli and molecular mechanisms of the
recombination. ALT telomeres are known to have high levels of DNA damage signals, and DNA
damaging agents can increase particular ALT characteristics (Cesare et al., 2009; Fasching et al.,
2007). A recent study from our lab using a telomere-specific endonuclease (TRF1–FokI) provided
definitive proof that DSB responses at telomeres initiate recombination in ALT (Cho et al., 2014).
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Specifically, telomere damage led to a homology search characterized by long-range directed
telomere movement across microns of nucleoplasm to capture another telomere. The damageinitiated movement and clustering were dependent on the essential recombination protein
RAD51. Surprisingly, the meiotic HOP2–MND1 heterodimer, which stimulates RAD51- and
DMC1-mediated recombination during meiosis (Petukhova et al., 2005; 2003), was also essential
for movement and clustering of ALT telomeres (Cho et al., 2014). Other repair proteins suggested
to impact ALT telomere maintenance include MRN, SMC5/6, FEN1, MUS81, BLM, FANCD2, and
SMARCAL1 (Cox et al., 2016; Fan et al., 2009; Jiang et al., 2005; Poole et al., 2015; Potts and
Yu, 2007; Root et al., 2016; Saharia and Stewart, 2009; Zeng et al., 2009; Zhong et al., 2007).
While it is still unclear in what capacity all these factors contribute to ALT, it appears that ALT
employs multiple repair pathways and specialized forms of HDR.

IV. Current gaps in knowledge
HDR pathways make up a fundamental branch of the DDR, operating on DSBs,
replicative lesions, and telomeres through templated DNA synthesis (Ciccia and Elledge, 2010;
Jasin and Rothstein, 2013). The physiologic relevance of these pathways is underscored by their
clear impact on cancer development, aging, and genetic syndromes. While exogenous sources of
DNA damage, such as -irradiation and site-specific nucleases, have been essential to our
current mechanistic understanding of mammalian HDR, it is becoming clear that endogenous
sources of damage engage a complex network of repair pathways, many of which are proving to
be non-canonical in nature (Verma and Greenberg, 2016). The mechanistic details of these
mammalian HDR pathways at replication forks and telomeres, particularly the regulation and
execution of templated DNA repair synthesis remain fundamental gaps in our knowledge.
BIR pathways are employed in response to one-ended DSBs, which are likely the most
common type of DSB, thereby repairing replicative lesions and maintaining telomeres in the
absence of telomerase (Anand et al., 2013). Despite being thoroughly characterized in yeast, BIR
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has remained elusive in mammalian cells largely due to a lack of tools to directly study these
processes. Recent studies have provided the first insights into mammalian BIR, documenting
POLD3-dependent DNA repair synthesis in response to replication stress (Costantino et al.,
2014; Minocherhomji et al., 2015). However, many important questions were raised by these
findings. ALT represents a clinically relevant and tractable system to study such questions related
to mammalian HDR synthesis, BIR, and telomere maintenance. Indeed, telomeres represent an
experimentally advantageous system since they are a defined, abundant locus and the dissection
of telomere repair synthesis mechanisms is expected to provide important insights into repair
synthesis elsewhere in the genome. While it is clear that ALT occurs by HDR and is a nexus of
many repair pathways, the mechanisms of telomere repair synthesis and whether they resemble
BIR are unknown. Specifically, it will be important to first address several basic questions: 1) Can
ALT telomere synthesis be monitored directly? 2) Does synthesis depend on RAD51 homology
searches? 3) What are the replication components that contribute to this synthesis? 4) Is
telomere repair synthesis important for ALT telomere maintenance?
The mechanisms of templated DNA synthesis are assumed to distinguish BIR from GC
and S-phase replication, however all HDR processes rely on some degree of templated synthesis
and therefore the action of a replisome. Importantly, very little is known about the mechanisms of
HDR synthesis broadly in mammalian cells. This often-overlooked process is responsible for
generating the nascent sequences of all repair products and therefore critical to understand.
Future studies should focus on deciphering the mechanisms of DNA repair synthesis at damaged
replication forks and ALT telomeres. Findings must be interpreted in light of other described HDRsynthesis pathways, with attempts to recognize unifying or distinguishing characteristics. It will be
critical to define the components of the replisomes used for different repair processes and figure
out how they are regulated to control localization, execution, and coordination with the multitude
of other chromatin processes. Other key areas to focus on include determining the endogenous
sources of damage that lead to repair synthesis, the homology-pairing mechanisms that promote
repair synthesis, the mutagenicity of repair synthesis, and the relevance of repair synthesis and
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replisome regulation to human disease. The subsequent chapters of this thesis address many of
the fundamental questions outlined here using ALT telomeres as a model system to study DNA
repair synthesis.
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CHAPTER 2: BREAK-INDUCED TELOMERE SYNTHESIS UNDERLIES
ALTERNATIVE TELOMERE MAINTENANCE

This chapter is adapted from
Dilley RL, Verma P, Cho NW, Winters HD, Wondisford AR, Greenberg RA. Break-induced
telomere synthesis underlies alternative telomere maintenance. Nature 2016 Nov
3;539(7627):54-58. doi: 10.1038/nature20099. (Dilley et al., 2016)

I. Abstract
Homology-directed DNA repair is essential for genome maintenance through templated
DNA synthesis. Alternative lengthening of telomeres (ALT) necessitates homology-directed DNA
repair to maintain telomeres in about 10-15% of human cancers. How DNA damage induces
assembly and execution of a DNA replication complex (break-induced replisome) at telomeres or
elsewhere in the mammalian genome is poorly understood. Here we define break-induced
telomere synthesis (BITS) and demonstrate that it utilizes a specialized replisome, which
underlies ALT telomere maintenance. DNA double-strand breaks enact nascent telomere
synthesis by long-tract unidirectional replication. Proliferating cell nuclear antigen (PCNA) loading
by replication factor C (RFC) acts as an initial sensor of telomere damage to establish
predominance of DNA polymerase δ (Pol δ) through its POLD3 subunit. Break-induced telomere
synthesis requires the RFC-PCNA-Pol δ axis, but is independent of other canonical replisome
components, ATM and ATR, or the homologous recombination protein Rad51. Thus, the
inception of telomere damage recognition by the break-induced replisome orchestrates
homology-directed telomere maintenance.
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II. Introduction
Tremendous progress has been made in identifying the events responsible for
recognizing and repairing DNA double-strand breaks (DSBs) (Ciccia and Elledge, 2010). A
complex aspect of this response is homology-directed DNA repair (HDR), which can involve
numerous possibilities to capture homologous regions of the genome to use for templated DNA
synthesis and repair. The detailed order of molecular events that ensues after the initial sensing
of DSBs to allow the execution of homology-directed synthesis remains enigmatic. Specifically,
how the DNA damage response coordinates productive interactions between DNA replication
complexes to perform break-induced DNA synthesis has not been extensively demonstrated in
mammalian cells. ALT is a clinically relevant example of a DNA repair pathway that requires
homology-directed synthesis to maintain telomeres in ~10–15% of human cancers (Bryan et al.,
1995; Cesare and Reddel, 2010). Additionally, such synthesis could represent an attractive
therapeutic target against cancers, especially if it proves to be different from canonical S-phase
replication.

III. Telomere breaks stimulate long-tract synthesis
To study homology-directed synthesis at ALT telomeres, we developed a
bromodeoxyuridine (BrdU) pulldown approach to isolate and quantify nascent telomeres
synthesized following telomere-targeted DSBs generated by the fusion of the Shelterin
component TRF1 to the FokI endonuclease (Fig. 2.1A). Using stable ALT-positive U-2 OS cell
lines expressing TRF1–FokI under tetracycline-control, a 2 h damage induction with wild-type
TRF1–FokI, but not the FokI (D450A) nuclease-null mutant, resulted in a ~10-fold increase in
nascent telomere synthesis in asynchronous and G2-enriched cells (Fig. 2.1B, C and Fig.
2.S1A–G). Concurrent synthesis of nascent C- and G-rich telomere strands was evident from 1 h
post-induction and became maximal at ~2 h (Fig. 2.1D). Nascent Alu repeat DNA was not
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increased by TRF1–FokI expression, demonstrating the specificity of break-induced telomere
synthesis (BITS) (Fig. 2.1D).
To understand the nature of individual DNA synthesis events, we adapted the singlemolecule analysis of replicated DNA (SMARD) technique for studying BITS (Norio and
Schildkraut, 2001; Sfeir et al., 2009). After induction of TRF1–FokI, U-2 OS cells were
sequentially incubated with iododeoxyuridine (IdU) and chlorodeoxyuridine (CIdU), genomic DNA
was digested, and telomere fragments were isolated on the basis of size (Fig. 2.1E). The
percentage of telomeres with IdU/CIdU incorporation increased with the duration of TRF1–FokI
induction (Fig. 2.1F, G). BITS proceeded in a unidirectional fashion, often to the end of the
telomere fragment. Nascent telomere tracts ranged in length from 5 to 70 kilobases (kb), with a
median value of 19.8 kb (n = 46) that matched the median length of the overall telomere fibres
observed (20.1 kb; n = 45) (Fig. 2.1H). Furthermore, ~80% of nascent telomere fragments were
completely labelled and ~98% of nascent fragments had label on at least one of the ends. Taken
together, these data suggest that DSBs at ALT telomeres induce long-tract telomeric DNA
synthesis.
As a complementary approach, BrdU immunofluorescence at telomeres provides a
means to assess spontaneous synthesis of ALT telomeres. Cell lines that utilize ALT, but not
telomerase, displayed elevated BrdU incorporation at telomeres in a pattern distinct from S-phase
replication (Fig. 2.S2A, B, D), consistent with previous reports (Nabetani et al., 2004). TRF1–FokI
expression increased analogue incorporation at ALT telomeres in interphase and metaphase
cells (Fig. 2.S2C, E), suggesting that telomere damage may be an initiating event for
spontaneous ALT telomere synthesis (Cho et al., 2014).
Expanding on our observations, we generated a panel of TRF1–FokI inducible lines from
cells that either utilize ALT (U-2 OS, VA13, SKNFI) or telomerase (HeLa 1.3, HeLa S3, 293T) for
telomere maintenance. Notably, all lines showed evidence of BITS by BrdU pulldown upon
induction with TRF1–FokI (Fig. 2.S3A–C). This holds true not only across telomere maintenance
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mechanism, but also regardless of ATRX status, overall telomere length differences, and cell type
(Fig. 2.S3A). Notably, a recent study provided evidence that replication stress can activate ALT
mechanisms in primary and telomerase-positive cells (O'Sullivan et al., 2014). We propose that
although any cell may have the capacity for BITS, ALT-positivity entails greater levels of telomere
damage that promotes homology-directed DNA synthesis and telomere maintenance. Therefore,
non S-phase telomere synthesis (Fig. 2.S2A, B, D) is apparent at baseline only in ALT cells.

IV. BITS by alternative HDR
Genetic studies in yeast demonstrated that break-induced replication is responsible for
telomere recombination, which can proceed through Rad51-dependent and -independent
mechanisms (Chen et al., 2001; Le et al., 1999; Lundblad and Blackburn, 1993; Lydeard et al.,
2007; Malkova et al., 1996; Teng and Zakian, 1999; Teng et al., 2000). Rad51, together with the
Hop2–Mnd1 heterodimer, localize to ALT-associated PML bodies (APBs) and facilitate longrange telomere movement and clustering in ALT cells (Cho et al., 2014; Cox et al., 2016; Yeager
et al., 1999). Cells lacking Hop2 from CRISPR–Cas9-mediated excision showed reduced
telomere clustering, APB formation, and telomere exchanges in ALT-positive VA13 cells (Fig.
2.S4A–F). ATR is a damage-sensing kinase that signals replication stress and is important for
ALT telomere integrity and cell survival (Flynn et al., 2015). Disruption of ATR and Chk1
signalling by knockdown and small-molecule inhibitors reduced Hop2 recruitment to telomeres
after TRF1–FokI induced damage, whereas ATM disruption had no effect (Fig. 2.2A). Similarly,
ATR knockdown restricted telomere mobility after TRF1–FokI induction in U-2 OS cells (Fig.
2.2B), thus implicating ATR and Rad51–Hop2 as critical for ALT telomere mobility.
We next asked whether ATR and Rad51–Hop2 are required for BITS. Surprisingly, ATR,
Rad51, and Hop2 were all dispensable for synthesis. Conversely, knockdown of each gene
paradoxically increased levels of nascent telomeres, which held true over an 8-h time course
(Fig. 2.2C and Fig. 2.S5A). Similarly, spontaneous ALT telomere synthesis did not require Rad51
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(Fig. 2.S5E, I). To investigate the long-term consequences of depletion of this pathway, we
examined the telomere length of VA13 HOP2 CRISPR clones. All of the 6 clones lacked
detectable Hop2 protein expression, with no telomere shortening observed at approximately
population doubling (PD) 25 or longer time points (Fig. 2.S4G, H). Collectively, this provides
evidence for Rad51-independent mechanisms of mammalian BITS and ALT telomere
maintenance. Although ATR regulates damage signalling, telomere integrity, and survival in ALT
cells, our data suggest it is not an essential component of the break-induced replisome at
telomeres.

V. BITS requires Pol δ
We next surveyed the replisome dependencies of BITS. Replicative DNA polymerases
Pol δ, Pol ε, and Pol α-primase were previously implicated in yeast break-induced replication
(Lydeard et al., 2007; 2010). Pol δ, including the POLD3 and POLD4 accessory and POLD1
catalytic subunits, was required for BITS (Fig. 2.2D, E and Fig. 2.S5A, B, D). Unexpectedly, Pol
δ was required for synthesis of both C- and G-rich telomere strands, whereas Pol ε and Pol αprimase were dispensable as was the MCM2-7 replicative helicase (Fig. 2.2D, F). Notably,
depletion of POLD3 resulted in ~2.5-fold less incorporation of IdU/CIdU in telomere fibres after
TRF1–FokI-induced breaks (Fig. 2.2G). POLD3 is also part of the Pol ζ complex involved in
translesion synthesis (Baranovskiy et al., 2012; Johnson et al., 2012; Makarova et al., 2012).
However, the catalytic subunit of Pol ζ (REV3L) as well as the other translesion synthesis
proteins Pol η (POLH) and REV1 were not needed for BITS (Fig. 2.2D and Fig. 2.S5C).
Therefore, the major function of POLD3 in BITS is through Pol δ. Notably, the requirements for
BITS using TRF1–FokI faithfully recapitulate the requirements for spontaneous ALT telomere
synthesis. Specifically, non S-phase telomere synthesis in three ALT lines required POLD3/Pol δ,
but occurred independently of Pol ε, Pol α, and Pol ζ (Fig. 2.S5F–I). Collectively, these data
define a non-canonical replisome involved in ALT telomere synthesis.
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VI. RFC–PCNA is an initial sensor of telomere damage
Pol δ showed robust recruitment to TRF1–FokI damage sites in U-2 OS cells, whereas
Pol ε, Pol α-primase, and MCM2-7 were present at much lower levels (Fig. 2.3A and Fig. 2.S6A,
B). POLD3 facilitates interaction of the Pol δ complex with the PCNA clamp for processive
synthesis and strand displacement (Ducoux et al., 2001). Notably, Pol δ has higher affinity for
PCNA than does Pol ε, and PCNA is known to function in repair processes outside S-phase
(Chilkova et al., 2007; Karras and Jentsch, 2010). Deletion of the PCNA-interacting peptide (PIP)
box (Δ456–466) of POLD3 disrupted its recruitment to damage sites (Fig. 2.3B). Functionally,
PCNA interaction with POLD3 facilitates recruitment of the whole Pol δ complex to damaged ALT
telomeres (Fig. 2.S6C, D). The RFC1–5 clamp loading complex was required for PCNA–POLD3
telomere localization, whereas the alternative clamp loader subunit, Rad17 was dispensable (Fig.
2.3C). Furthermore, the entire axis consisting of RFC1–PCNA–POLD3 localized in an inducible
fashion to ~90% of damaged ALT telomeres and was required for BITS (Fig. 2.3D, Fig.
2.S5H, Fig. 2.S6E, F).
Both PCNA and POLD3 showed ~10-fold increases in telomere localization by 30 min
after induction with TRF1–FokI (Fig. 2.3E). By contrast, Rad51 localization occurred more slowly
and was maximal by 2 h after induction (Fig. 2.3E). Peak telomere synthesis coincided with an
increase in DSB signalling (Fig. 2.1D and Fig. 2.3E). Time-lapse imaging revealed that GFP–
PCNA localized to TRF1–FokI damage sites soon after they became visible and before ALT
telomere merging events (Fig. 2.3F, n = 20 cells). Consistent with PCNA loading being an early
damage response, its localization was independent of proximal damage response factors ATR,
ATM, MRE11, or homologous recombination proteins Rad51, Hop2, and BRCA2 (Fig. 2.3G).
Importantly, RFC1, PCNA, and POLD3 spontaneously localized to ~2–10% of telomeres
specifically in ALT-positive cells, consistent with the presence of persistent damage at a subset of
ALT telomeres (Yeager et al., 1999) (Fig. 2.3H). These data reveal that PCNA loading is an initial
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damage sensor at ALT telomeres, thus establishing a platform to assemble the break-induced
replisome.

VII. POLD3 is critical for ALT telomere maintenance
Pol32, the yeast homologue of POLD3, is required for recombination dependent survivors
of telomerase defiency (Lydeard et al., 2007). Transient knockdown of POLD3 decreased
spontaneous ALT telomere synthesis and single-telomere-exchange events by chromosome
orientation fluorescence in situ hybridization (CO–FISH), but had no immediate effect on C-circles
or telomere length (Fig. 2.S5F–I and Fig. 2.S7A, B). We investigated the consequences of
prolonged POLD3 depletion on ALT telomere maintenance using CRISPR–Cas9 in U-2 OS cells.
Although we were unable to generate surviving cells with complete loss of POLD3, we obtained 4
clones (c1–c4) with in-frame deletions and residual expression of POLD3 (Fig. 2.S7C–G).
Notably, all 4 clones had reduced levels of the entire Pol δ complex (Fig. 2.4A and Fig. 2.S7G),
consistent with a stabilizing role for POLD3 (Murga et al., 2016). Clones c1–c3 displayed
accelerated telomere shortening at ~PD 25 compared to the empty guide control, whereas clone
c4 had a more minor phenotype (Fig. 2.4B and Fig. 2.S7H, I). Telomere length in 5 clones with
normal POLD3 expression (c5–c9) was unchanged at ~PD 25 (Fig. 2.S8A). The telomere
shortening observed in clones c1–c3 is greater than expected for cells lacking a telomere
maintenance mechanism, representing a loss of ~800–1200 bp of telomeric repeats per cell
division. However, telomeres did not continue to shorten over time in these clones. This is
consistent with accelerated shortening and stabilization observed in other ALT lines in which
telomere maintenance mechanisms have been partially impaired (Zhong et al., 2007). Additional
U-2 OS POLD3 CRISPR clones from an independent guide RNA also displayed shortened
telomeres compared to the parental line or clones derived from the same guide RNA that failed to
exhibit reduced POLD3 expression, making it unlikely that the effects observed are due to clonal
variation (Fig. 2.S8C). Collectively, analysis of the mean telomere length of the 31 clones from
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both of the guide RNAs revealed a significant decrease in clones with reduced POLD3
expression compared to those with normal POLD3 expression (Fig. 2.4C). In contrast, telomere
length changes were not observed in 11 POLD3 CRISPR clones from telomerase-positive HeLa
1.3 cells (Fig. 2.S8D–F), suggesting an increased requirement of POLD3 for processive telomere
synthesis during ALT.
U-2 OS POLD3 CRISPR clones accumulated increased numbers of telomere
dysfunction-induced foci (TIFs) (Fig. 2.4D and Fig. 2.S7I). C-circles are another marker of
telomere maintenance specific to ALT-dependent cells (Henson et al., 2009). Clones c1–c3 had
significantly decreased levels of C-circles that could be rescued by reconstituting wild-type
POLD3, whereas clones c5–c9 did not display similar reductions (Fig. 2.4E, Fig. 2.S7I–K, Fig.
2.S8B). These data are consistent with a partial disruption of ALT activity and telomere
maintenance in clones c1–c3 (Fig. 2.S7I). We propose that POLD3 is critical for the majority of
nascent telomere synthesis during ALT and therefore underlies long-term telomere maintenance
and ALT activity.

VIII. Discussion
Direct visualization of the dynamic process of ALT telomere recombination reveals that
rapid RFC-mediated PCNA loading at damaged telomeres is an initial sensor of telomere
damage, thus connecting DSB recognition with the assembly of a specialized replisome capable
of executing BITS (Fig. 2.4F). On the other hand, Rad51 and Hop2 loading and long-range
homology searches occur more slowly and are dispensable for the bulk of homology-directed
DNA synthesis at telomeres (Fig. 2.4F). We postulate that PCNA can load at alternative
structures with recessed 3′-ends and preferentially recruit Pol δ owing to its higher affinity for
PCNA compared with that of Pol ε (Chilkova et al., 2007). In contrast to yeast break-induced
replication, Rad51 and Pol α-primase were not required for BITS. A repertoire of Rad51independent mechanisms available to damaged telomeres, such as intra-telomere annealing or
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association with extrachromosomal telomere repeats that are abundant in ALT cells may bypass
the need for Rad51 and Pol α-mediated priming (Cesare and Reddel, 2010). Persistent damage
at ALT telomeres probably promotes Rad51 and other competing repair mechanisms with
differing kinetics of homology-directed telomere synthesis (Cho et al., 2014; Yeager et al.,
1999) (Fig. 2.4F). We speculate that related processes are invoked at other vulnerable regions of
the genome (Costantino et al., 2014; Mayle et al., 2015; Minocherhomji et al., 2015; Miyabe et al.,
2015; Verma and Greenberg, 2016). The unique characteristics that differentiate this mechanism
from scheduled S-phase replication may facilitate a better understanding of how alternative repair
mechanisms enable genome evolution and enhance cancer cell fitness.

IX. Materials and Methods
Cell culture
U-2 OS, HeLa 1.3, HeLa S3, DLD-1, and 293T cell lines were grown in DMEM (Thermo Fisher)
with 10% calf serum and 1% penicillin/streptomycin. VA13, GM847, LM216T, and LM216J cell
lines were grown in DMEM (Thermo Fisher) with 10% FBS and 1% penicillin/streptomycin. SKNFI
cell line was grown in RPMI (Thermo Fisher) with 10% FBS and 1% penicillin/streptomycin. VA13
cell line refers to WI-38 VA-13 subline 2RA. LM216T/J are matched lines. Cell lines were
obtained from ATCC and tested negative for Mycoplasma using the MycoAlert PLUS
Mycoplasma Detection Kit (Lonza). The U-2 OS TRF1–FokI inducible cell line was authenticated
by STR analysis (ATCC). Other lines were validated by ALT characteristics. None of the cell lines
used is listed as commonly misidentified by the International Cell Line Authentication Committee
(ICLAC).
ALT-positive lines used: U-2 OS, VA13, GM847, LM216J, SKNFI
ALT-negative lines used: HeLa 1.3 (long telomere), HeLa S3, DLD-1, LM216T, 293T
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BrdU immunofluorescence
Cells were pulsed with 100 μM BrdU (Sigma) for 2 h before fixation. After permeabilization, cells
were denatured with 500 U ml−1 DNaseI (Roche) in 1× reaction buffer (20 mM Tris-HCl (pH 8.4),
2 mM MgCl2, 50 mM KCl in PBST) for 10–25 min at 37 °C in a humidified chamber. Coverslips
were then washed and incubated with anti-BrdU antibody (BD) for 20 min at 37 °C followed by
secondary antibody and telomere FISH. For metaphases, cells pulsed with BrdU were treated
with 100 ng ml−1colcemid for 90 min followed by 75 mM KCl for 30 min. Cells were fixed in 3:1
methanol:acetic acid, dropped onto slides, and allowed to dry overnight. Denaturation was
performed with 2 N HCl for 30 min at room temperature followed by antibody incubations as
described above.

BrdU pulldown dot blot
BrdU pulldown was adapted from a published protocol (Viggiani et al., 2010). Cells were pulsed
with 100 μM BrdU (Sigma) for 2 h before collection. Genomic DNA (gDNA) was isolated using
phenol–chloroform extraction followed by resuspension in TE buffer. gDNA was then sheared into
100–300 bp fragments using a Covaris S220 sonicator. 1–4 μg sheared gDNA was denatured for
10 min at 95 °C and cooled in an ice-water bath. Denatured gDNA was incubated with 2 μg antiIgG (Sigma) or anti-BrdU antibody (BD) diluted in immunoprecipitation buffer (0.0625% (v/v)
Triton X-100 in PBS) rotating overnight at 4 °C. The next day, samples were incubated with 30 μl
Protein G magnetic beads (Pierce) that had been pre-bound to a bridging antibody (Active Motif)
for 1 h rotating at 4 °C. Beads were subsequently washed three times with immunoprecipitation
buffer and once with TE buffer. Beads were then incubated twice in elution buffer (1% (w/v) SDS
in TE) for 15 min at 65 °C. Pooled eluate was cleaned with ChIP DNA Clean & Concentrator kit
(Zymo). Samples, along with 10% inputs, were diluted into 2× SSC buffer, treated at 95 °C for
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5 min, and dot-blotted onto an Amersham Hybond-N+ nylon membrane (GE). The membrane was
then denatured in a 0.5 N NaOH 1.5 M NaCl solution, neutralized, and ultraviolet crosslinked. The
membrane was hybridized with 32P-labelled (TTAGGG)6oligonucleotides, unless otherwise noted,
in PerfectHyb Plus Hybridization Buffer (Sigma) overnight at 37 °C. The next day, the membrane
was washed twice in 2× SSC buffer, exposed onto a storage phosphor screen (GE Healthcare)
and scanned using STORM 860 with ImageQuant (Molecular Dynamics). All quantifications were
performed in Fiji and normalized to 10% input.

Telomere single-molecule analysis of replicated DNA (SMARD)
The SMARD assay was performed as previously described (Norio and Schildkraut, 2001; Sfeir et
al., 2009). U-2 OS cells were induced with TRF1–FokI for 20 min or 2 h and were subsequently
labelled by incubating with 30 μM IdU for 2 h, followed by 30 μM CIdU for the next 2 h. After
pulsing, 106 labelled cells per condition were embedded in 1% agarose and lysed using
detergents (100 mM EDTA, 0.2% sodium deoxycholate, 1% sodium lauryl sarcosine and 0.2 mg
ml−1Proteinase K). The plugs were then washed several times with TE, treated with 100 μM
PMSF, and then washed again with TE buffer followed by incubation with 1× Cut-Smart buffer
(NEB) for 30 min. The DNA in the plugs was then digested overnight at 37 °C using 50 U of both
MboI and AluI (NEB) per plug. The digested plugs were then cast into a 0.7% low-melting point
agarose gel and a distinct fragment running above 10 kb (containing telomeric DNA defined by
Southern blotting) was excised, melted and stretched on slides coated with 3aminopropoyltriethoxysilane (Sigma-Aldrich). After denaturation of the DNA strands using alkali
buffer (0.1 M NaOH in 70% ethanol and 0.1% β-mercaptoethanol), the DNA was fixed using 0.5%
glutaraldehyde and incubated overnight with biotin-OO-(CCCTAA)4 locked nucleic acid (LNA)
probe (Exiqon) at 37 °C. Telomere FISH probes were then detected using the Alexa Fluor 405conjugated streptavidin (Thermo-Fisher) followed by sequential incubation with the biotinylated
anti-avidin antibody (Vector Laboratories) and additional Alexa 405-conjugated streptavidin. IdU
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and CldU were visualized using mouse anti-IdU (BD) and rat anti-CIdU (Serotec) monoclonal
antibodies followed by Alexa Fluor 568-goat anti-mouse and Alexa Fluor 488-goat anti-rat
secondary antibodies (Life Technologies). Images were acquired using the NIS-element software
(Nikon) and a Nikon eclipse 80i microscope equipped with a 63× objective and a Cool Snap
camera (MYO). For calculating the length of the telomeres and replication tracts, the line-scan
function from Image J was used. For conversion of microns to kilobases, as 10 bp (equals one
turn of the helix) has a linear length of 3.4 nm, 0.26 microns corresponded to 1 kb of DNA.

Plasmids, primers, siRNAs, and CRISPR sgRNAs
Death domain (DD)–Oestrogen receptor (ER)–mCherry–TRF1–FokI and Flag–TRF1–FokI
constructs were cloned as previously described (Cho et al., 2014). Doxycycline-inducible TRF1–
FokI lines were generated using the Tet-On 3G system. Briefly, Flag–DD–ER–mCherry–TRF1–
FokI was cloned into the pLenti CMV TRE3G Puro Dest vector, which was introduced into cells
engineered to co-express the reverse tetracycline transactivator 3G (rtTA3G). N-terminal GFPtagged proteins were generated by PCR amplification and ligation of cDNAs from the ProQuest
HeLa cDNA Library (Invitrogen) into the pDEST53 (Invitrogen) mammalian expression vector.
CRISPR lines were generated using a two-vector system (pLentiCas9-Blast and pLentiGuidePuro). POLD3 reconstitution vector was generated by cloning POLD3 cDNA (RefSeq
NM_006591.2) into the pOZ–N–Flag–HA retroviral vector followed by site-directed mutagenesis
of siRNA binding sites. Sanger sequencing of POLD3 CRISPR clones was performed on gDNA
fragments cloned into a TOPO TA vector (Thermo Fisher).
Transient plasmid transfections were carried out with LipoD293 (Signagen), and siRNA
transfections with Lipofectamine RNAiMax (Invitrogen) according to manufacturer’s instructions.
Analyses were performed 16 h after transfection of plasmids, and 72 h after siRNA transfection.
All siRNAs were used at a final concentration of 20 nM.
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The following primers were used for qRT–PCR:
POLD3 primer set 1: 5′-GAGTTCGTCACGGACCAAAAC-3′, 5′-GCCAGACACCAAGTAGGTAAC3′;
POLD3 primer set 2: 5′-ACCAACAAGGAAACGAAAACAGA-3′, 5′GGTTCCGTGACAGACACTGTA-3′;
The following siRNA sequences were used:
Control siRNA (siCtrl): QIAGEN AllStars Negative Control siRNA;
ATR siRNA (siATR): 5′-AACCUCCGUGAUGUUGCUUGAdTdT-3′;
ATM siRNA (siATM): 5′-GCGCCUGAUUCGAGAUCCUdTdT-3′;
RAD51 siRNA (siRAD51): #1, 5′-UGUAGCAUAUGCUCGAGCG-3′, #2, 5′CCAGAUCUGUCAUACGCUA-3′;
HOP2 siRNA (siHOP2): #2, 5′-AAGAGAAGAUGUACGGCAA-3′, #3, 5′UCUGCUUAAAGGUGAAAGUAGCAGG-3′;
BRCA2 siRNA (siBRCA2): 5′-GAAGAAUGCAGGUUUAAU-3′;
RFC1 siRNA (siRFC1): 5′-GAAGGCGGCCUCUAAAUCAUU-3′;
RAD17 siRNA (siRAD17): 5′-CAGACUGGUUGACCCAUCUU-3′;
PCNA siRNA (siPCNA): 5′-GGAGGAAGCUGUUACCAUAUU-3′;
MRE11 siRNA (siMRE11): Dharmacon SMARTpool M-009271-01-0005;
POLD3 siRNA (siPOLD3): #1, Invitrogen 4390824-s21045, #2, Invitrogen 4392420-s21046;
POLD1 siRNA (siPOLD1): #1, Invitrogen 4392420-s615, #2, Invitrogen 4392420-s616;
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POLD4 siRNA (siPOLD4): 5′-GCAUCUCUAUCCCCUAUGAUU-3′;
POLE siRNA (siPOLE): #1, 5′-GGACAGGCGUUACGAGUUCUU-3′; #2, 5′CUCGGAAGCUGGAAGAUUAUU-3′;
POLA1 siRNA (siPOLA1): #1, Invitrogen 4392420-s10772, #2, Invitrogen 4392420-s10774;
REV3L siRNA (siREV3L): 5′-CCCACUGGAAUUAAUGCACAAUU-3′;
PRIM1 siRNA (siPRIM1): Invitrogen HSS108448;
MCM2 siRNA (siMCM2): Invitrogen HSS106390;
MCM7 siRNA (siMCM7): Invitrogen HSS106405;
POLH siRNA (siPOLH): 5′-CTGGTTGTGAGCATTCGTGTA-3′;
REV1 siRNA (siREV1): 5′-ATCGGTGGAATCGGTTTGGAA-3′;
Knockdown efficiencies were evaluated by western blot (Fig. 2.S9).
The following CRISPR sgRNA sequences were used:
sgPOLD3: #1, 5′-GCAGATAAAGCTGGTCCGCCA-3′, #2, 5′-GAAATATAGACGAGTTCGTCA-3′;
sgHOP2: #1, 5′-GCCGGACGTTGTAGTTGCTCG-3′, #2, 5′-GCGGGAAAGGCGATGAGTAA-3′,
#3, 5′-GCGGGAGGTAACGGCGCCGT-3′, #4, 5′-GAGTAGATTCACCCGTTGTC-3′, #5, 5′GACCCATGAGAGCCCGACAAC-3′.

Antibodies
The following antibodies were used: anti-BrdU (mouse B44, BD 347580; rat BU1/75, AbD Serotec
OBT0030G), anti-ATRX (rabbit H-300, Santa Cruz sc-15408), anti-53BP1 (rabbit, Novus NB100-
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904), anti-γH2AX (mouse JBW301, Millipore 05-636), anti-Flag (mouse M2, Sigma F1804), antiPML (mouse PG-M3, Santa Cruz sc-966), anti-Rad51 (rabbit H-92, Santa Cruz sc-8349; mouse
14B4, Abcam ab-213), anti-Hop2/PSMC3IP (rabbit, Novus NBP1-92301), anti-POLD3 (mouse
3E2, Abnova H00010714-M01), anti-POLD1 (mouse 607, Abcam ab10362; rabbit, Bethyl A304005A), anti-POLD2 (rabbit, Bethyl A304-322A), anti-POLD4 (mouse 2B11, Abnova H00057804M01A), anti-POLE (mouse 93H3A, Pierce MA5-13616; rabbit, Novus NBP1-68470), anti-POLE3
(rabbit, Bethyl A301-245A), anti-POLA1 (rabbit, Bethyl A302-851A), anti-MCM7 (rabbit, Bethyl
A302-584A), anti-MCM4 (rabbit, Bethyl A300-193A), anti-MCM5 (rabbit, Abcam ab75975), antiRFC1 (rabbit, Bethyl A300-320A), anti-PCNA (mouse PC10, CST #2586) anti-ATR (goat N-17,
Santa Cruz sc-1887), anti-PRIM1 (rabbit H300, Santa Cruz sc-366482), anti-Rad17 (goat, Bethyl
A300-151A), anti-REV3L (rabbit, GeneTex GTX100153), anti-POLH (rabbit, Bethyl A301-231A),
anti-REV1 (rabbit H300, Santa Cruz sc-48806) anti-GAPDH (rabbit 14c10, CST #2118), antiαTubulin (mouse TU-02, Santa Cruz sc-8035).

Drugs
Doxycycline was used at a concentration of 40 ng ml −1 for 16–24 h to induce expression of TRF1–
FokI. Shield-1 (Cheminpharma LLC) and 4-hydroxytamoxifen (4-OHT) (Sigma-Aldrich) were both
used at a concentration of 1 μM for 2 h, unless otherwise stated, in to allow for TRF1–FokI
stabilization and translocation into the nucleus. RO-3306 (Selleck Chemicals) was used at a
concentration of 10 μM for 20–24 h. G2 enrichment was confirmed by propidium iodide staining
and flow cytometry. Colcemid (Roche) was used at a concentration of 100 ng ml−1. The ATR
inhibitor VE-821 (Selleck Chemicals) and Chk1 inhibitor LY2603618 (Selleck Chemicals) were
used at a concentration of 5 μM and 1 μM respectively for 24 h.

Western blot
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Cells were lysed in RIPA buffer supplemented with cOmplete protein inhibitor cocktail (Roche)
and Halt phosphatase inhibitor cocktail (Thermo) on ice and subsequently spun down at max
speed at 4 °C. The supernatant was removed and protein concentration determined using the
Protein Assay Dye Reagent (Bio-Rad). 20–40 μg of protein was run on a 4–12% Bis–Tris gel
(Invitrogen). Proteins were transferred onto an Amersham Protran 0.2 μm nitrocellulose
membrane (GE) and blocked with 5% milk. Membranes were incubated with primary antibodies
overnight at 4 °C. The next day membranes were incubated with secondary antibodies for 1 h at
room temperature and subsequently developed using Western Lightning Plus-ECL (Perkins
Elmer) or SuperSignal West Femto (Thermo).

Immunofluorescence, immunofluorescence–FISH, TIF assay, APB assay, and CO-FISH
Cells grown on coverslips were fixed in 4% paraformaldehyde for 10 min at room temperature.
Coverslips were then permeabilized in 0.5% Triton X-100 for 5 min at 4 °C (for most antibodies) or
100% cold methanol for 10 min at −20 °C (for anti-PCNA). Primary antibody incubation was
performed at 4 °C in a humidified chamber overnight unless otherwise indicated. Coverslips were
washed and incubated with appropriate secondary antibody for 20 min at 37 °C, then mounted
onto glass slides using Vectashield mounting medium with DAPI (Vector Labs). For
immunofluorescence–FISH, coverslips were re-fixed in 4% paraformaldehyde for 10 min at room
temperature after secondary antibody binding. Coverslips were then dehydrated in an ethanol
series (70%, 90%, 100%) and allowed to air dry. Dehydrated coverslips were denatured and
incubated with TelC–Cy3 peptide nucleic acid (PNA) probe (Panagene) in hybridization buffer
(70% deionized formamide, 10 mM Tris (pH 7.4), 0.5% Roche blocking solution) overnight at
room temperature in a humidified chamber. The next day, coverslips were washed and mounted
as described above. Images were acquired with a QImaging RETIGA-SRV camera connected to
a Nikon Eclipse 80i microscope. For TIF assay, cells were scored for co-localized 53BP1 and
telomere foci by immunofluorescence–FISH. For APB assay, cells were scored for the number of
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PML–telomere colocalizations by immunofluorescence–FISH. Hop2 immunofluorescence and
CO–FISH experiments were performed as previously described (Cho et al., 2014).

Pulsed-field gel electrophoresis and in-gel hybridization
Telomere gels were performed using telomere restriction fragment (TRF) analysis. Genomic DNA
was digested using AluI and MboI (NEB). 4–10 μg of DNA was run on a 1% PFGE agarose gel
(Bio-Rad) in 0.5× TBE buffer using the CHEF-DRII system (Bio-Rad) at 6 V cm−1; initial switch
time 5 s, final switch time 5 s, for 16 h at 14 °C. The gel was then dried for 4 h at 50 °C, denatured
in a 0.5 N NaOH 1.5 M NaCl solution, and neutralized. Gel was hybridized with 32P-labelled
(CCCTAA)6oligonucleotides in Church buffer overnight at 42 °C. The next day, the membrane
was washed four times in 4× SSC buffer, exposed onto a storage phosphor screen (GE
Healthcare) and scanned using STORM 860 with ImageQuant (Molecular Dynamics). Telomere
length was determined using TeloTool software (Göhring et al., 2014).

C-circle assay
C-circle assay was performed as previously described (Henson et al., 2009). Genomic DNA was
digested using AluI and MboI (NEB). 30 ng of digested DNA was combined with 0.2 mg ml−1 BSA,
0.1% Tween, 1 mM each dNTP without dCTP, 1× ϕ29 Buffer (NEB) and 7.5 U ϕ29 DNA
polymerase (NEB). Samples were incubated for 8 h at 30 °C followed by 20 min at 65 °C.
Samples were then diluted in 2× SSC buffer and dot-blotted onto an Amersham Hybond-N+ nylon
membrane (GE). Membrane was ultraviolet crosslinked and then hybridized with
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P-labelled

(CCCTAA)6oligonucleotides in PerfectHyb Plus Hybridization Buffer (Sigma) overnight at 37 °C.
The next day, the membrane was washed twice in 2× SSC buffer, exposed onto a storage
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phosphor screen (GE Healthcare) and scanned using STORM 860 with ImageQuant (Molecular
Dynamics).

Co–immunoprecipitation and chromatin immunoprecipitation (ChIP)
Cells were lysed in HEPES immunoprecipitation buffer (10 mM HEPES (pH 8), 2 mM EDTA,
0.1% NP-40) supplemented with 5 mM DTT, 1 mM PMSF, and 1× cOmplete protein inhibitor
cocktail (Roche) on ice and subsequently spun down at max speed at 4 °C. The supernatant was
removed and protein concentration determined using the Protein Assay Dye Reagent (Bio-Rad).
25 μg protein was removed for input. 500 μg protein was diluted to 1 mg ml−1 in HEPES
immunoprecipitation buffer and pre-cleared with 10 μl Protein G magnetic beads (Pierce) for 1 h
rotating at 4 °C. Protein lysate was then incubated with 10 μg anti-IgG (Sigma) or anti-POLD1
antibody (Abcam) rotating overnight at 4 °C. The next day, samples were incubated with 30 μl
Protein G magnetic beads (Pierce) that had been pre-bound to a bridging antibody (Active Motif)
for 1 h rotating at 4 °C. Beads were subsequently washed five times with HEPES
immunoprecipiation buffer. Proteins were eluted by incubating beads with 2× sample buffer with
BME for 5 min at 95 °C. Samples were analysed by western blot. ChIP was performed as
previously described and analysed by western blot and dot blot (Tang et al., 2013).

Telomere content dot blot
400 ng of genomic DNA was diluted into 2× SSC buffer, treated at 95 °C for 5 min, and dot-blotted
onto an Amersham Hybond-N+ nylon membrane (GE). Membrane was then denatured in a 0.5 N
NaOH 1.5 M NaCl solution, neutralized, and UV crosslinked. Membrane was hybridized with 32Plabelled (CCCTAA)6, or Alu repeat oligonucleotides in PerfectHyb Plus Hybridization Buffer
(Sigma) overnight at 37 °C. The next day, the membrane was washed twice in 2× SSC, exposed
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onto a storage phosphor screen (GE Healthcare) and scanned using STORM 860 with
ImageQuant (Molecular Dynamics).

Live cell imaging and image analysis
Live cell imaging was performed and analysed as previously described (Cho et al., 2014). Fixed
cell and live cell images were captured at 60× and 100× magnification, respectively. Microscope
images and dot blots were prepared and analysed using Fiji. Southern blot telomere gel images
were prepared using Fiji and were not cropped to exclude any part of the presented lanes.
Western blot gel images were prepared using Adobe Photoshop and cropped to present relevant
bands.

Statistics
All statistical analysis was done using GraphPad Prism 5 software. Unpaired t-tests were used to
generate two-tailed P values.
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Figure 2.1. Break-induced telomere synthesis (BITS) occurs by long-tract unidirectional
telomeric recombination.
(A) Schematic of BrdU pulldown. IP, immunoprecipitation.
(B–D), BrdU pulldown dot blot for telomere content using a 32P-labelled telomere oligonucleotide
(B) from U-2 OS cells induced (Ind) with TRF1–FokI for 2 h, with quantification (C) and time
course of C- and G-rich telomere strands compared to Alu repeats (D).
(E) Schematic of telomere SMARD.
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(F–H), Representative images (F) of telomere (blue) labelled with IdU (red) and CldU (green)
from U-2 OS cells induced (Ind) with TRF1–FokI, with quantification (G) and length of telomere
fibres (H). Median length quantified ± 95% C.I.
WT, wild-type; D450A, nuclease-null mutant. Data represent mean ± s.e.m. of three (C) or two (G)
independent experiments. **P ≤ 0.01, *P ≤ 0.05.
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Figure 2.2. BITS occurs by alternative HDR and utilizes a non-canonical replisome defined
by Pol δ.
(A) Quantification of co-localized Hop2 and telomere foci in TRF1–FokI expressing VA13 cells
treated with the indicated small interfering RNAs (siRNAs) or inhibitors.
(B) Mean squared displacement (MSD) analysis of live-cell telomere movement from U-2 OS
cells following TRF1–FokI induction.
(C–F) BrdU pulldown dot blots for telomere content (C, D, E, F) from U-2 OS cells induced (Ind)
with TRF1–FokI for 2 h, with rescue experiment (E), and quantifications (C, D, F).
(G) Quantification of telomere SMARD from U-2 OS cells induced with TRF1–FokI and treated
with the indicated siRNAs.
EV, empty vector; WT, reconstituted POLD3. Data represent mean ± s.e.m. of at least two
independent experiments. ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05.
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Figure 2.3. Rapid loading of PCNA acts as an initial sensor of telomere damage.
(A) Quantification of co-localized GFP-tagged replisome subunits and telomere foci from U-2 OS
cells induced with TRF1–FokI for 2 h.
(B) Schematic of POLD3 and representative images of POLD3 deletion mutants.
(C) Quantification of co-localized endogenous PCNA and POLD3 and telomere foci from U-2 OS
cells induced with TRF1–FokI for 2 h.
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(D) BrdU pulldown dot blot for telomere content from U-2 OS cells induced (Ind) with TRF1–FokI
for 2 h.
(E) Kinetics of PCNA and POLD3 loading at damaged telomeres in relation to Rad51, γH2AX,
and DNA synthesis in U-2 OS cells. IF, immunofluorescence.
(F) Representative live-cell imaging of PCNA recruitment to damaged telomeres before telomere
clustering in U-2 OS cells. Time in minutes shown in upper left corners.
(G) Quantification of the requirements for PCNA loading at damaged telomeres in U-2 OS cells.
(H) Quantification of spontaneous co-localized RFC1, PCNA, and POLD3 and telomere foci from
a panel of ALT– and ALT+ cell lines.
Fixed cell and live cell images were captured at 60× and 100× magnification, respectively. Data
represent mean ± s.e.m. of two (A) or three (C, E, G, H) independent experiments. ****P ≤ 0.0001.

Figure 2.4. POLD3 is critical for telomere maintenance in ALT-dependent cells.
(A) Analysis of Pol δ protein expression by western blot from U-2 OS CRISPR clones (sgPOLD3)
with decreased POLD3 expression (c1–c4) compared to empty guide control (sgEmpty). GAPDH
is used as a loading control. Darker exposure shown in Extended Data Fig. 7g.
(B) TRF analysis using pulsed-field gel electrophoresis from U-2 OS clones c1–c4 at ~PD 25.
Peak intensity of telomere length is indicated by red dot.
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(C) Quantification of relative mean telomere length in 31 pooled sg POLD3 clones from two
independent guide RNAs with normal and decreased POLD3 protein expression.
(D, E) Analysis of telomere maintenance by TIF quantification (co-localized 53BP1 and telomere
foci) (D) and C-circle assay (E) from U-2 OS clones c1–c4.
(F) Model.
Data represent mean ± s.e.m. of three independent experiments. ****P ≤ 0.0001, ***P ≤ 0.001,
*P ≤ 0.05.

Figure 2.S1. An inducible system for studying BITS.
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(A) Schematic of inducible TRF1–FokI system.
(B–D), Characterization of U-2 OS inducible TRF1–FokI system by western blot (B),
immunofluorescence (C), and telomere ChIP (D).
(E) Agarose gel of sonicated DNA prepared for BrdU pulldown.
(F, G) BrdU pulldown dot blot for telomere content (F) from asynchronous or G2-enriched U-2 OS
cells induced (Ind) with TRF1–FokI for 2 h, with cell-cycle profiles by propidium iodide staining
(G).
Images were captured at 60× magnification. Dox, doxycycline; S, Shield-1; T, 4hydroxytamoxifen; DD, destabilization domain; ER, oestrogen receptor; rtTA, reverse tetracycline
transactivator; TRE3G, tetracycline response element; WT, wild-type; D450A, nuclease-null
mutant.

Figure 2.S2. Visualization of spontaneous ALT telomere synthesis.
(A–C) BrdU immunofluorescence assay to visualize spontaneous ALT telomere synthesis, with
representative images of VA13 cells (A) and quantification of a panel of ALT– and ALT+ cell lines
(B) and U-2 OS cells induced with TRF1–FokI for 2 h (C).
(D, E) Representative images of BrdU immunofluorescence of metaphases from spontaneous
GM847 cells (D) and U-2 OS induced (+Ind) with TRF1–FokI for 2 h upon release from RO-3306
(E).

40

Images were captured at 60× magnification. Data represent mean ± s.e.m. of three independent
experiments. ***P ≤ 0.001.

Figure 2.S3. BITS occurs independently of telomere maintenance mechanism.
(A) A panel of ALT− and ALT+ inducible TRF1–FokI cell lines tested for TRF1–FokI and ATRX
expression by western blot and nascent telomere synthesis by BrdU pulldown dot blot for
telomere content after induction (Ind) with TRF1–FokI for 2 h.
(B, C) BrdU pulldown dot blot for telomere content (B) from HeLa 1.3 cells induced (Ind) with
TRF1–FokI for 2 h, with quantification (C).
Data represent mean ± s.e.m. of two independent experiments. *P ≤ 0.05.
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Figure 2.S4. Hop2 contributes to telomere clustering but is dispensable for telomere
length maintenance.
(A–H) CRISPR/Cas9-mediated excision of HOP2 (sgHOP2) in VA13 cells, with western blot of
populations (A). Analysis of Hop2 co-localization with telomere foci by IF-FISH (B), telomere
focus size by FISH (C), APBs by PML co-localization with telomere foci (D, E), and telomere
exchanges by CO-FISH (F) from sgHOP2 #2 population. Analysis of clones (c1–c6) by western
blot (G) and TRF pulsed-field gel at ~PD 25 (H).
Peak intensity of telomere length is indicated by red dot. Images were captured at 60×
magnification. Data represent mean ± s.e.m. of at least two independent experiments.
***P < 0.0005, **P < 0.005, *P < 0.05.
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Figure 2.S5. Requirements for break-induced and spontaneous ALT telomere synthesis.
(A) BrdU pulldown dot blot timecourse for telomere content from U-2 OS induced (Ind) with
TRF1-FokI for indicated times and treated with indicated siRNAs.
(B, C) BrdU pulldown dot blots for telomere content from U-2 OS induced (Ind) with TRF1–FokI
for 2 h and treated with indicated siRNAs.
(D) BrdU pulldown dot blot for telomere content from HeLa 1.3 induced (Ind) with TRF1–FokI for
2 h and treated with indicated siRNAs, with quantification.
(E–I) Analysis of spontaneous ALT telomere synthesis using BrdU immunofluorescence from
VA13 (E–H) and GM847 and LM216J (I) treated with indicated siRNAs.
Images were captured at 60× magnification. Data represent mean ± s.e.m. of two (D) or three (E–
I) independent experiments. ****P ≤ 0.0001, **P ≤ 0.01, *P ≤ 0.05.

43

Figure 2.S6. Pol δ predominates at ALT telomeres.
(A) Representative images of replisome components (green) and telomere foci (red) from U-2 OS
induced with TRF1–FokI for 2 h.
(B) western blot of Pol δ complex from cell lines treated with TRF1–FokI. Asterisk denotes nonspecific band.
(C, D) Quantification of co-localized POLD3 (C) or POLD1 (D) with telomere foci from U-2 OS
induced with TRF1–FokI for 2 h.
(E, F) Representative images (E) of co-localized RFC1-PCNA-POLD3 (green) and telomere foci
(red) from U-2 OS induced with TRF1–FokI for 2 h, with quantification (F).
WT = wild-type, D450A = nuclease-null mutant. Images were captured at 60× magnification. Data
represent mean ± s.e.m. of three independent experiments. ****P ≤ 0.0001, ***P ≤ 0.001.
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Figure 2.S7. POLD3 is critical for telomere maintenance in ALT-dependent cells.
(A, B) analysis of transient POLD3 depletion by C-circle dot blot (A) from U-2 OS and CO-FISH
(B) from VA13 (n = 1780 ends for siCtrl, n = 1637 ends for siPOLD3).
(C) TRF analysis from U-2 OS populations at ~PD 25. Peak intensity of telomere length is
indicated by red dot.
(D) schematic of U-2 OS POLD3 CRISPR (sgPOLD3) cloning strategy with western blot.
(E–G), analysis of POLD3 expression from U-2 OS clones c1–c4 by qPCR (E), POLD1 Co–IP
(F), and darker exposure of western blot from Fig. 4a (G). Asterisk denotes non-specific band.
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(H), Quantification of relative telomere content by dot blot from U-2 OS clones c1–c4.
(I) Heat map summarizing decreases (blue), increases (red), or no change (white) in telomere
maintenance from U-2 OS clones c1–c4 as compared to U-2 OS control.
(J, K) POLD3-reconstituted CRISPR clones analysed for C-circles by dot blot (J) and Pol δ
expression by western blot (K).
EV, empty vector; WT, reconstituted POLD3. Data represent mean ± s.e.m. of two independent
experiments. **P ≤ 0.01, *P ≤ 0.05.

Figure 2.S8. Extended analysis of POLD3 CRISPR clones.
(A, B) TRF analysis by pulsed-field gel (A) and C-circle dot blot (B) from U-2 OS POLD3 CRISPR
(sgPOLD3) clones with normal POLD3 expression (c5–c9) at ~PD 25.
(C) U-2 OS POLD3 CRISPR clones from an independent guide RNA (sgPOLD3 #2) analysed by
TRF and western blot at ~PD 25.
(D) TRF analysis by pulsed-field gel from HeLa 1.3 populations at ~PD 25.
(E) Schematic of HeLa 1.3 POLD3 CRISPR cloning strategy with western blot.
(F) TRF analysis by pulsed-field gel from HeLa 1.3 clones c1–c11 at ~PD 25. Peak intensity of
telomere length is indicated by red dot.
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Figure 2.S9. Knockdown efficiencies.
(A–N) Western blots of U-2 OS or VA13 cells treated with indicated siRNAs. Asterisk denotes
non-specific band.
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CHAPTER 3: TELOMERE REPAIR SYNTHESIS IS CONTROLLED BY RAD52

The work for this chapter was done in close collaboration with Priyanka Verma, Ph.D., who
initiated and performed the majority of the RAD52 experiments.

I. Abstract
ALT telomere maintenance occurs through alternative homology-directed repair (HDR)
that requires POLD3-dependent templated DNA synthesis. However, the spontaneous initiating
lesions, molecular machinery, and physiological relevance of this synthesis are not fully
understood. Here, we demonstrate that break-induced telomere synthesis (BITS) escapes mitotic
inhibition, confirming the utilization of a non-canonical HDR mechanism. By screening in mitosis,
we identify RAD52 as an alternative repair factor that responds to DNA damage at ALT telomeres
and controls spontaneous telomere repair synthesis. As such, loss of RAD52 results in telomere
shortening and a concomitant reduction in total telomere content and C-circles. However, RAD52
is dispensable for BITS and cell viability, suggesting the existence of multiple pathways
contributing to ALT downstream of replicative lesions and DSBs. A targeted CRISPR screen
reveals that RAD52 deficient ALT cells are hypersensitive to loss of the structure-specific
nuclease scaffold SLX4. Our studies establish that ALT involves a multitude of repair pathways
and delineate the molecular mechanism by which RAD52 contributes to telomere maintenance.
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II. Introduction
Homology-directed DNA repair (HDR) can be achieved through multiple pathways with
distinct molecular machinery and regulation (Verma and Greenberg, 2016). Canonical HDR
proceeds through a RAD51-dependent search and capture of a homologous sequence followed
by templated DNA synthesis. However, non-canonical forms of HDR independent of RAD51 have
been extensively described in yeast and are responsible for a subset of break-induced replication
(BIR) and telomere maintenance in telomerase-negative survivors (Chen et al., 2001; Le et al.,
1999; Lundblad and Blackburn, 1993; Lydeard et al., 2007; Malkova et al., 1996; Teng and
Zakian, 1999; Teng et al., 2000). Analogous mechanisms in human cells are increasingly
believed to underlie the repair of damaged replication forks and the alternative lengthening of
telomeres (ALT) pathway of telomere maintenance used by a subset of cancers (Cesare and
Reddel, 2010; Costantino et al., 2014). However, the relative contribution of canonical vs. noncanonical HDR to these pathways in humans is poorly understood. We have recently
demonstrated that human break-induced telomere synthesis (BITS) and spontaneous ALT
telomere synthesis are independent of RAD51 (Dilley et al., 2016). The molecular control of this
alternative form of HDR remains a fundamental question.
Yeast telomerase-negative survivors require HDR for telomere maintenance and survival,
analogous to human ALT. While Type II survivors are Rad51-independent, both Type I and II
require the repair protein Rad52 and the DNA polymerase  subunit Pol32 (Lundblad and
Blackburn, 1993; Lydeard et al., 2007). The mammalian homolog of Pol32, POLD3, was recently
shown to be important for human ALT, but the potential role of RAD52 has not been thoroughly
investigated (Dilley et al., 2016; Roumelioti et al., 2016). Drawing parallels between yeast and
human RAD52 may prove challenging since the cellular function does not appear to be fully
conserved. While yeast Rad52 is an important mediator of Rad51-nucleofilament formation, this
function has largely been taken over by BRCA2 in human cells (Hanamshet et al., 2016).
Biochemically, human RAD52 binds dsDNA and ssDNA and promotes the annealing between
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complementary ssDNA strands as well as D-loop formation in vitro (Benson et al., 1998; Kagawa
et al., 2001; 2002; Van Dyck et al., 1999; 2001). In vivo, mammalian RAD52 was thought to
mainly participate in alternative, backup repair pathways (Cramer-Morales et al., 2013; Feng et
al., 2011; Hanamshet et al., 2016; Lok et al., 2013; Rijkers et al., 1998; Yamaguchi-Iwai et al.,
1998; Yáñez and Porter, 2002). However, recent studies identified an essential role for RAD52 in
DNA repair synthesis after replication stress in human cells (Bhowmick et al., 2016; Sotiriou et al.,
2016). These RAD52-dependent repair pathways are independent of RAD51 and can occur in
mitosis (MiDAS), a time when canonical HR and NHEJ are repressed (Bhowmick et al., 2016;
Giunta et al., 2010; Heijink et al., 2013; Minocherhomji et al., 2015; Orthwein et al., 2014; Özer
and Hickson, 2018; Silva et al., 2014). RAD52-dependent mitotic repair synthesis was also
observed at ALT telomeres (Min et al., 2017; Özer et al., 2018). However, the physiological
importance of RAD52-mediated synthesis to ALT remains enigmatic. In this study, we set out to
investigate the contributions of non-canonical repair pathways to ALT. Our studies reveal that
multiple repair pathways operating during various stages of the cell cycle contribute to ALT
telomere synthesis. We found that RAD52 plays an essential role in controlling G2-phase ALT
telomere synthesis and length maintenance. A targeted CRISPR screen of DNA repair proteins
identified factors that cooperate with RAD52 to promote viability and ALT.

III. BITS escapes mitotic inhibition
DNA double strand break (DSB) repair is controlled throughout the cell cycle (Hustedt
and Durocher, 2016). In mitosis, a series of phosphorylation events effectively inhibits canonical
HR and NHEJ, whereas alternative forms of repair such as MiDAS are permitted (Minocherhomji
et al., 2015; Orthwein et al., 2014). Since BITS occurs by alternative HDR independent of RAD51,
we hypothesized that it would escape mitotic inhibition (Dilley et al., 2016). To test this, we
isolated arrested mitotic cells using nocodazole shakeoff or RO-3306 release followed by
shakeoff and subsequently turned on TRF1-FokI to create telomere breaks in mitosis. TRF1-FokI
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induction for 2 h resulted in activation of ATM signaling in mitotic cells as indicated by increased
p-KAP1 (Fig. 3.1A). During this timeframe, break-induced replisome components POLD3 and
PCNA localized to damaged mitotic telomeres, whereas RAD51 and 53BP1 were excluded (Fig.
3.1B-D). As seen for asynchronous cells, mitotic telomere damage resulted in the generation of
C-circles as well as a dramatic increase in POLD3-dependent nascent telomere synthesis using
the BrdU pulldown assay (Cho et al., 2014; Dilley et al., 2016; Verma et al., 2018) (Fig. 3.1E-K,
Fig. 3.S1A-D). Spontaneous mitotic telomere synthesis was present at higher levels in several
ALT cell lines compared to telomerase lines (Fig. 3.S1E-G), consistent with recent work (Min et
al., 2017; Özer et al., 2018). However, the baseline synthesis was negligible compared to that
seen after TRF1-FokI in both ALT and telomerase lines (Fig. 3.1G, H). Taken together, our data
demonstrate that telomere repair synthesis escapes mitotic inhibition and can occur in direct
response to breaks generated in mitosis. In addition to highlighting the non-canonical nature of
this HDR and the importance of the POLD3 replisome, our data suggest that mitosis could serve
as a window to screen for repair factors critical to telomere synthesis and repair.

IV. RAD52 is recruited to ALT telomeres to resolve replication stress
Human RAD52 participates in alternative repair pathways independent of RAD51
(Bhowmick et al., 2016; Sotiriou et al., 2016). RAD52 has been visualized at ALT telomeres and
contributes to telomeric MiDAS, but its functional role in human ALT remains poorly understood
(Min et al., 2017; Özer et al., 2018; Yeager et al., 1999). Taking advantage of the mitotic
repression of canonical repair pathways, we found that RAD52 localized to damaged mitotic
telomeres as well as interphase telomeres (Fig. 3.2A). RAD52 telomere localization increased in
G2 arrested cells and was more prominent in ALT cell lines compared to telomerase lines,
suggesting a damage dependence (Fig. 3.2B, C). Indeed, generation of telomere DSBs using
TRF1-FokI resulted in increased RAD52 recruitment to these damage sites (Fig. 3.2D).
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Interestingly, replication stress due to hydroxyurea (HU) treatment as well as CRISPR targeting
FANCD2 (sgFANCD2) also resulted in increased RAD52 recruitment to telomeres (Fig. 3.2E, F).
Our data suggest that RAD52 is part of a repertoire of alternative repair proteins that can
localize to damaged mitotic chromatin and may have a role in responding to replication stress at
telomeres. To directly test this we measured C-circles, which are a marker of ALT activity that are
proposed to arise from resolution of replication stress intermediates (Henson et al., 2009;
O'Sullivan et al., 2014; Rivera et al., 2017). FANCD2 loss, which increases replication stress and
RAD52 telomere recruitment (Fig. 3.2F), increased C-circles in ALT cells (Fig. 3.S2A-C),
consistent with previous reports (Fan et al., 2009; Root et al., 2016). Nascent C-circle generation
was highest in G2 arrested cells and decreased dramatically as cells entered mitosis in both
control and sgFANCD2 cells (Fig. 3.S2D). These data imply that ALT activity is increased in G2
in response to replication stress, consistent with the increased recruitment of RAD52 to telomeres
during this phase (Fig. 3.2B). CRISPR guides targeting RAD52 (sgRAD52) reduced C-circles in
G2 arrested and asynchronous cells, as well as mitotic cells induced with TRF1-FokI (Fig. 3.2G,
H and Fig 3.S2E). Notably, this C-circle reduction was consistent across two independent guides
and in both cell populations and pooled clones (Fig. 3.2G, H and Fig 3.S3A-C). While sgFANCD2
and sgPOLD3 had opposing effects on C-circles in G2, RAD52 knockout (KO) had a dominant
effect, leading to a reduction in all genetic backgrounds (Fig. 3.2I, J and Fig 3.S2F). Taken
together, our data demonstrate that RAD52 responds to replication stress at the telomere and
can likely resolve this stress through ALT-associated repair pathways.

V. RAD52 is required for spontaneous ALT telomere synthesis and maintenance
Loss of factors important for ALT telomere synthesis, such as POLD3 and BLM, results in
a decrease in C-circles (Dilley et al., 2016; Sobinoff et al., 2017). Since RAD52 loss also reduces
C-circles we hypothesized that it might be involved in directing DNA repair synthesis at ALT
telomeres downstream of replication stress. To test this directly we analyzed the effect of RAD52
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depletion on non S-phase telomere synthesis, a characteristic found only in ALT cells (Cho et al.,
2014; Dilley et al., 2016). LM216J ALT cells treated with three independent sgRAD52 guides
displayed a significant reduction in non S-phase telomere synthesis as measured by EdU
incorporation (Fig. 3.3A, B and Fig 3.S3D). Notably, depletion of RAD52 and POLD3 resulted in
similar reductions in telomere synthesis, with no obvious additive effect seen in combination (Fig.
3.3C). These results were validated using BrdU pulldowns of undamaged cells arrested in G2.
Using this approach, RAD52 KO also decreased spontaneous telomere synthesis in LM216J and
U-2 OS cells (Fig. 3.3D, E). This reduction in synthesis is likely due at least in part to diminished
PCNA loading onto ALT telomeres in G2 in RAD52 KO cells (Fig. 3.3F). Taken together, our data
define an essential role for RAD52 in controlling telomere repair synthesis in ALT cells.
To determine the importance of RAD52 for overall ALT telomere maintenance, we
analyzed telomere length and content in sgRAD52 populations and RAD52 KO clones. Telomere
length shortened in sgRAD52 U-2 OS cells as determined by TRF analysis (Fig. 3.4A, B). RAD52
KO clones also displayed a significant loss of telomere content by qFISH and dot blot in U-2 OS
and LM216J, but not in the matched telomerase positive LM216T line (Fig. 3.4C, D). In
accordance with a reduced ability to resolve replication stress, RAD52 KO cells accumulated
RPA and ssDNA at telomeres (Fig. 3.4E, F). Despite complete KO of RAD52, cell viability was
not significantly compromised, suggesting that other repair factors are likely compensating or
acting in parallel to RAD52 to maintain ALT telomeres. Increased 53BP1 at telomeres in the
absence of RAD52 implies that DSBs can likely be repaired in a RAD52-independent manner to
maintain cell viability (Fig 3.4G). In line with this idea, RAD52 was dispensable for BITS after
TRF1-FokI generated DSBs (Fig. 3.4F). Our data indicate that in spontaneous ALT cells, RAD52
likely functions downstream of replication stress to direct POLD3-dependent telomere synthesis
and maintenance. On the other hand, RAD52-independent pathways must function in a subset of
DSB repair and ALT telomere maintenance.
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VI. CRISPR screening reveals sensitivities of RAD52 deficient ALT cells
We reasoned that RAD52 deficient ALT cells should be particularly sensitive to depletion
of DNA repair factors that mediate RAD52-independent telomere maintenance. We performed a
targeted CRISPR screen of candidate DNA repair proteins that have been previously implicated
in different aspects of recombination. The screen was performed in WT and RAD52 KO ALT
dependent LM216J cells. A sgRNA library consisting of 58 guides targeting 15 DNA repair
proteins with distinct functionalities, and six controls were designed and cloned into a lentiviral
vector that expresses GFP under the control of an internal ribosome entry sequence (IRES)
(Tarumoto et al., 2018) (Fig 3.5B). The number of sgRNAs designed per gene was based on
gene size and the number of functional domains. Targeting functional domains has been
documented to yield increased CRISPR Cas9 mediated knockout efficiency (Shi et al., 2015). WT
and RAD52 KO LM216J ALT cells stably expressing Cas9 were transduced with lentivirus
expressing sgRNAs and GFP as a tracker at a multiplicity of infection <0.5. These cells were
subsequently monitored for changes in the percentage of GFP positivity every two doubling times
for seven passages as a measure of cell proliferation/viability (Fig. 3.5A). While GFP percent
remained constant with each passage in cells targeted with negative controls (Fig. 3.5C), there
was a total reduction in GFP positivity over the course of the experiment in both WT and RAD52
KO cells treated with positive controls targeting essential proteins PCNA and RPA3. However, we
observed a significantly reduced editing efficiency in RAD52 KO cells, biasing our screen against
identifying hits where RAD52 KO cells were more sensitive than WT (Fig. 3.5C).
We observed three different growth/viability trends, denoted by Groups I-III (Fig 3.S4,
and Fig 3.5) Group I sgRNAs did not reduce the GFP positive population below 40% over 14
passage doublings in both WT and RAD52 KO cells. These genes included RAD54A, RAD54B,
MUS81, GEN1 and POLQ. (Fig. 3.S4). Group II sgRNAs significantly reduced the GFP positive
population below 40% in WT cells but not in RAD52 KO cells. This included RAD51 and its
paralogs (RAD51A, RAD51C, RAD51D, XRCC2, XRCC3) and FEN1. We attribute the diminished
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sensitivity of targeting these essential recombination factors, at least in part, to the reduced
editing efficiency in RAD52 KO cells (Fig. 3.5D). Group III sgRNAs significantly reduced the cell
growth/viability below 40% in WT and RAD52 KO cells. sgRNA against SLX4, FANCD2 and BLM
reduced cell growth/viability of WT and RAD52 KO cells to a comparable extent. Because of the
reduced targeting efficiency in cells lacking RAD52 (Fig. 3.5E), we propose that the magnitude of
effect of these genetic interactions is likely underrepresented in these experiments. SLX4 has
been reported to be epistatic to RAD52 during MiDAS at telomeres (Özer and Hickson, 2018;
Özer et al., 2018). However, our results may be indicative of non-overlapping functions of RAD52
and SLX4 in telomere maintenance during ALT.

VII. Discussion
Human RAD52 is an alternative repair protein that can localize to damaged chromatin in
G2/M and plays a critical role in responding to replicative lesions at telomeres and facilitating the
resultant repair synthesis. Recent studies have also identified an important role for RAD52 in the
response to replication stress in an array of settings (Bhowmick et al., 2016; Min et al., 2017;
Murfuni et al., 2013; Özer et al., 2018; Sotiriou et al., 2016). Our work is complementary to these
studies and expands upon them in several novel ways. We demonstrate that RAD52 is required
not only for mitotic telomere repair synthesis, but for controlling ALT telomere synthesis more
broadly, which occurs mostly outside mitosis. Additionally, we provide new evidence that RAD52
is required for a subset of ALT telomere maintenance. While not completely analogous to yeast
telomerase survivors, it is clear that human ALT is also comprised of multiple repair pathways
cooperating to maintain telomeres. As such, RAD52 deficient ALT cells continue to proliferate but
are rendered hypersensitive to the loss of the structure-specific nuclease scaffold SLX4. Our
current work is addressing the potential mechanisms of RAD52 and SLX4 cooperation to
maintain telomere stability and cell viability.
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We postulate that ALT proceeds via distinct repair pathways that respond to different
lesions, such as replication stress or DSBs at telomeres. RAD52-dependent resolution of
replication stress is likely activated more frequently and responsible for a large portion of POLD3dependent telomere synthesis. However, the balance between these repair pathways could shift
in response to genetic disruption of repair proteins, such as RAD52, or treatment with
chemotherapeutics or targeted inhibitors. RAD52 disruption is known to be synthetically lethal
with BRCA1/2 and recently demonstrated to enhance PARPi sensitivity (Chandramouly et al.,
2015; Cramer-Morales et al., 2013; Feng et al., 2011; Hengel et al., 2016; Huang et al., 2016; Lok
et al., 2013; Sullivan et al., 2016; Sullivan-Reed et al., 2018). The use of RAD52 inhibitors in
combination with other targeted therapies may also provide an opportunity to selectively kill ALT
tumors. While the importance of human RAD52 is becoming more evident, future progress will
depend on an understanding of the biochemical functions of RAD52 that facilitate these
alternative forms of repair.

VIII. Materials and Methods
Methods from Chapter 2 are not described again here. Please refer to that section for details.

Cell synchronizations
Unless otherwise indicated, mitosis arrested cells were isolated by shakeoff after ~16 h
incubation with 100 ng/ml nocodazole. Nocodazole remained in the media after shakeoff to
ensure continued arrest. Alternatively, cells were arrested in G2 with ~16 h incubation with 10 M
RO-3306 and subsequently released into nocodazole for 20 min before shakeoff. For sustained
G2 arrest cells were kept in RO-3306.
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siRNAs and CRISPR sgRNAs
The following siRNA sequences were used:
siControl: QIAGEN AllStars Negative Control siRNA
siPOLD3: Invitrogen 4392420-s21046
The following forward sgRNA sequences were cloned into plentiGuide-Puro:
sgRAD52: #1 5’-CACCGAGAATACATAAGTAGCCGCA-3’, #2 5’CACCGTCTGGCCTCCGCCAGCCATG-3’, #3 5’-CACCGGGCGGCTCAGTGTTATGCTT-3’
sgFANCD2: #1 5’-CACCGTACTGGAGGCATCTTCTGTC-3’, #2 5’CACCGAGATTTTGACAGTCTTCTTT-3’
sgPOLD3: 5′-CACCGCAGATAAAGCTGGTCCGCCA-3′

Antibodies
The following antibodies were used: anti-BrdU (mouse B44, BD 347580), anti-53BP1 (rabbit,
Novus NB100-904), anti-Flag (mouse M2, Sigma F1804), anti-Rad51 (mouse 14B4, Abcam ab213), anti-POLD3 (mouse 3E2, Abnova H00010714-M01), anti-PCNA (mouse PC10, CST #2586)
anti-GAPDH (rabbit 14c10, CST #2118), anti-αTubulin (mouse TU-02, Santa Cruz sc-8035), antipH3 S10 (rabbit, Millipore 06-570), anti-pKAP1 S824 (rabbit, Bethyl A300-767A), anti-pPLK1
T210 (rabbit, CST #5472), anti-RPA2 (mouse 9H8, Novus NB600-565), anti-FANCD2 (mouse
FI17, Santa Cruz sc-20022), anti-RAD52 (sheep, generous gift from Jiri Lukas).

Nascent C-circle assay
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BrdU pulldown of 2 g gDNA was performed as previously described with two major differences
(Dilley et al., 2016; Verma et al., 2018). First, sonication was omitted in order to preserve C-circle
structure. Instead, gDNA was digested using AluI and MboI (NEB). Second, the digested gDNA
was not denatured prior to pulldown. After BrdU pulldown, the nascent DNA was cleaned with
ChIP DNA Clean & Concentrator kit (Zymo) and eluted in 20 L. For C-circle PCR, 6 L of eluted
pulldown was used per reaction. Digested gDNA input (30 ng per reaction) was run in parallel.

GFP CRISPR screen
Individual sgRNAs for each gene was cloned into a lentiviral vector with a U6 promoter and an
IRIS GFP (kindly gifted by Dr. Junwei Shi at UPenn). Virus for sgRNAs was generated in a 96well format by transfecting HEK293T cells in each well with sgRNA containing vector (1050 ng),
pPAX2 (750ng) and pVSVG (500ng) using PEI. Virus were then transduced at an MOI of less
than 0.6 on Cas9 expressing LM216J WT or LM216J Rad52KO cells seeded in a 96-well plate.
The percent of GFP in each well was monitored using a Guava Easycyte HT instrument
(Milllipore) for seven population doublings after the second day of transduction (which
represented the day of maximum GFP expression). Live cells were gated using forward and side
scatter before measuring GFP positive cells.

IX. Figures
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Figure 3.1. BITS escapes mitotic inhibition.
(A) Western blot from asn and mitosis arrested U-2 OS induced with T1FI.
(B-D) Analysis of repair factor recruitment to damaged mitotic telomeres by immunofluorescence
of U-2 OS (B) and chromatin immunoprecipitation-dot blot from HeLa S3 (C) with quantification
(D).
(E, F) C-circle dot blot from mitosis arrested U-2 OS induced with T1FI (E) with quantification (F).
(G, H) BrdU pulldown dot blots for telomere content from mitosis arrested U-2 OS and HeLa S3
induced with T1FI (G), with quantification of nascent telomeric C- and G-strands (H).
(I) Western blot from asn and mitosis arrested U-2 OS treated with indicated siRNAs.
(J, K) BrdU pulldown dot blot for telomere content from mitotis arrested U-2 OS induced with T1FI
(J), with quantification of nascent telomeric C- and G-strands (K).
Asn, asynchronous; T1FI, TRF1-FokI; Noc, nocodazole. Data represent mean ± s.e.m. of two (D,
K) or three (F, H) independent experiments. *P ≤ 0.05.

59

Figure 3.2. RAD52 is recruited to ALT telomeres to resolve replication stress.
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(A) Representative image of RAD52-telomere colocalization in interphase and mitotis arrested U2 OS induced with T1FI.
(B-F) Quantification of the number of RAD52-telomere colocalizations per cell in G2 arrested cells
(B), a panel of telomerase positive and ALT positive lines (C), and cells treated with T1FI (D), HU
(E), and sgFANCD2 (F).
(G, H) C-circle dot blot from G2-arrested U-2 OS populations expressing two independent
sgRAD52 guides compared to empty control (sgEmpty) (G) with quantification (H).
(I, J) C-circle dot blot from G2-arrested LM216J WT vs. RAD52 KO expressing indicated sgRNAs
(I) with quantification (J).
Data represent mean ± s.e.m. of two (J) or five (H) independent experiments. ****P ≤ 0.0001,
***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05.
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Figure 3.3. RAD52 is required for spontaneous ALT telomere synthesis.
(A) Representative image of non S-phase EdU-telomere staining in LM216J WT vs. RAD52 KO.
(B, C) Quantification of % non S-phase cells with EdU-telomere colocalization in G2 arrested
LM216J populations expressing three independent sgRAD52 guides compared to empty control
(sgEmpty) (B), and LM216J WT vs. RAD52 KO pool expressing sgPOLD3 (C).
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(D, E) BrdU pulldown dot blot for telomere content from G2 arrested LM216J and U-2 OS WT vs.
RAD52 KO pool (D), with quantification (E).
(F, G) PCNA ChIP dot blot for telomere content from G2 arrested U-2 OS WT vs. RAD52 KO pool
(F), with quantification (G).
Data represent mean ± s.e.m. of three independent experiments. **P ≤ 0.01, *P ≤ 0.05.

Figure 3.4. RAD52 is required for a subset of ALT telomere maintenance.
(A, B) Analysis of telomere length by TRF from U-2 OS populations expressing three
independent sgRAD52 guides compared to empty control (EV) (A), with analysis over multiple
passages (B).
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(C, D) Analysis of telomere content in WT vs. RAD52 KO pools by qFISH (C) and telomere/alu
ratio by dot blot (D).
(E, F) Analysis of telomeric ssDNA in WT vs. RAD52 KO pools by immuno-FISH of RPA-telomere
colocalization (E), 2-D gel electrophoresis probed for telomeres (F).
(G) Quantification of % cells with 53BP1-telomere colocalization in U-2 OS WT vs. RAD52 KO
pool.
(H) Quantification of BrdU pulldown dot blot for telomere content from U-2 OS WT vs. RAD52 KO
clones induced with T1FI.
Data represent mean ± s.e.m. of three independent experiments. **P ≤ 0.01, *P ≤ 0.05.

63

Figure 3.5. CRISPR screening reveals sensitivities of RAD52 deficient ALT cells.
(A) Schematic of the experimental approach.
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(B) List of genes in the screen classified according to their functionalities
(C) Growth curves representing percent of GFP positive cells over seven passages. Each data
point represents the mean of two independent experiments. 2000 cells were analyzed at most
time points. Data points obtained from less than 500 cells were excluded from the analysis. Error
bar, SD.
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Figure 3.S1. Extended analysis of mitotic telomere synthesis.
(A) C-circle dot blot following BrdU pulldown of mitosis arrested U-2 OS induced with T1FI.
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(B-D) Analysis of mitotic BITS in U-2 OS induced with T1FI by BrdU-telomere colocalization (B),
quantification of dot blots for nascent telomere and alu content (C), and dot blot for nascent
telomere content after PLK1i shakeoff (D).
(E-G) Analysis of spontaneous mitotic telomere synthesis in a panel of ALT negative and ALT
positive lines with western blot (E) and dot blot for telomere content (F) with quantification (G).
Data represent mean ± s.e.m. of two independent experiments.

Figure 3.S2. FANCD2 and RAD52 have opposing effects on C-circles.
(A-C) C-circle dot blot from U-2 OS populations expressing two independent sgFANCD2 guides
compared to empty control (sgEmpty) (A) with quantification (C) and western blot (B).
(D) Quantification of C-circle dot blots from gDNA and BrdU pulldowns in U-2 OS populations at
different cell cycle phases expressing sgFANCD2 compared to empty control (sgEmpty).
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(E) Quantification of C-circle dot blots from gDNA and BrdU pulldowns in mitosis arrested U-2 OS
populations expressing indicated sgRNAs and treated with T1FI.
(F) Western blot from G2-arrested LM216J WT vs. RAD52 KO expressing indicated sgRNAs.
Rel, release; SO, shakeoff. Data represent mean ± s.e.m. of two (D, E) or three (C) independent
experiments. *P ≤ 0.05.

Figure 3.S3. Extended analysis of RAD52 depleted cells.
(A, B) Western blots of sgRAD52 populations (A) and RAD52 KO pools (B).
(C) C-circle dot blot from asynchronous WT vs. RAD52 KO pools with quantification.
(D) Quantification of % non S-phase cells with EdU-telomere colocalization in asynchronous
LM216J WT vs. RAD52 KO pool.
Data represent mean ± s.e.m. of three independent experiments. ****P ≤ 0.0001, ***P ≤ 0.001,
*P ≤ 0.05.
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Figure 3.S4. Extended analysis of CRISPR screen.

Graphs showing percent of GFP positive cells over seven passages. Each data point represents
the mean of two independent experiments. 2000 cells were analyzed at most time points. Data
points obtained from less than 500 cells were excluded from the analysis. Error bar, SD.

CHAPTER 4: PROTEOMIC ANALYSIS OF THE POLD3 REPLICATION COMPLEX
REVEALS NOVEL INTERACTIONS

I. Abstract
POLD3 is a core component of the DNA polymerase  (Pol ) and Pol  complexes
essential for a diverse array of DNA replication and repair processes essential to cell viability. The
protein interactions that regulate the POLD3 replication complex to control its localization,
execution, and coordination with other chromatin activities remain poorly understood. To address
this, we purify the POLD3 replication complex and analyze its interactions using mass
spectrometry. As expected, POLD3 has major interactions with Pol  members POLD1 and
POLD2, as well as minor interactions with the catalytic subunit of Pol , REV3L, as well as REV1,
and FANCD2-I. Surprisingly, we identify an interaction with SPATA5L1, an uncharacterized AAA
ATPase. SPATA5L1 localizes to chromatin, replication forks, and damaged telomeres and is
required for cell viability and genome stability, defining an essential role for this new protein. In
summary, the POLD3 replication complex comprises many putative novel interactions expected
to impact replication and repair processes.

II. Introduction
The eukaryotic DNA replication machinery coordinates faithful duplication of the genome
and participates in many DNA repair pathways both during and outside S-phase (Burgers and
Kunkel, 2017; Hübscher et al., 2002). Replicative DNA polymerases are particularly important for
extensive templated DNA synthesis during homology-directed repair (HDR) mechanisms,
including break-induced replication (BIR) and alternative lengthening of telomeres (ALT) (Anand
et al., 2013; Kramara et al., 2018; Lange et al., 2011; Li and Heyer, 2008; Pâques and Haber,
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1999). How these polymerases are regulated to control timely localization, execution, and
coordination with the multitude of other chromatin processes is a fundamental question.
DNA polymerase  (Pol ) is an essential replicative polymerase involved in the bulk of Sphase synthesis and numerous repair processes (Prindle and Loeb, 2012). Mammalian Pol  is a
four-subunit complex composed of the catalytic subunit POLD1 and the accessory subunits
POLD2, POLD3, and POLD4. Mechanistically, POLD3 controls the stability of the Pol  complex
and its interaction with the PCNA clamp for processive synthesis (Ducoux et al., 2001; Murga et
al., 2016). POLD3 is also a member of the Pol  complex involved in translesion synthesis (TLS)
(Baranovskiy et al., 2012; Johnson et al., 2012; Makarova et al., 2012). Recent studies have
uncovered an essential role for POLD3 in mediating a diverse array of HDR processes, including
repair of damaged replication forks/BIR, mitotic repair synthesis (MiDAS), break-induced telomere
synthesis (BITS), and ALT (Costantino et al., 2014; Dilley et al., 2016; Garcia-Exposito et al.,
2016; Lemaçon et al., 2017; Minocherhomji et al., 2015; Roumelioti et al., 2016; Sobinoff et al.,
2017; Tumini et al., 2016). However, a thorough characterization of the POLD3 interactome was
lacking. Here we purify the POLD3 replication complex and discover novel interactions expected
to be important for replication and repair.

III. Purification of the POLD3 replication complex
POLD3 is a core member of the Pol  and Pol  complexes. We hypothesized that
POLD3 binding partners would provide insights into the regulation of POLD3-dependent
replication and repair processes important for normal and cancer cell viability. To discover these
binding partners, we performed large-scale tandem affinity purifications of HeLa S3 cells stably
expressing a functional FLAG-HA tagged POLD3 (FH-POLD3) or FH-PCNA for comparison
(Dilley et al., 2016). Cells were untreated or induced with TRF1-FokI for 2 h to activate BITS
mediated repair (Fig. 4.1A, B). Silver staining of purified FH-POLD3 samples revealed major
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bands corresponding to the size of POLD1, POLD2, and POLD3 at near equal stoichiometric
ratios as well as numerous minor bands (Fig. 4.1C and Fig. 4.S1A, B). Purified samples were
trichloroacetic acid (TCA) precipitated and analyzed by mass spectrometry. As expected, the top
hits were POLD1, POLD2, and POLD3 for the FH-POLD3 samples and PCNA for the FH-PCNA
samples (Fig. 4.1D). While Pol  and PCNA were identified in the reciprocal purifications, they
were present at low levels compared to the bait indicating that these complexes were largely
segregated using our purification method (Fig. 4.1D and Fig. 4.S1B).
By analyzing unique peptides found only in FH-POLD3 samples and not in FH-PCNA,
REV3L and FANCI were identified as top hits in both untreated and TRF1-FokI samples (Fig.
4.1E, and Fig. 4.S1C, D). REV3L is the catalytic subunit of the TLS polymerase Pol  and a
known binding partner of POLD3. We also found interactions of POLD3 with REV1, another TLS
polymerase that cooperates with Pol , and FANCD2, the binding partner of FANCI involved in
the Fanconi anemia (FA) pathway and protection of replication forks (Fig. 4.1E, and Fig. 4.S1C,
D) (Ceccaldi et al., 2016). These interactions were validated in asynchronous and mitotic cells
using co-immunoprecipitation (CoIP) (Fig. 4.1F and Fig. 4.S1E, F). Additionally, the interaction
with FANCD2-I was independent of DNA damage and required the N-terminal POLD2-interacting
domain of POLD3 (1-144) but not the C-terminal PCNA-interacting domain (456-466) (Fig. 4.1G
and Fig. 4.S1E, F).
Overall, 222 proteins with at least 2 unique peptides were present in both untreated and
TRF1-FokI induced FH-POLD3 samples, but not in FH-PCNA (Fig. 4.1H). Gene ontology (GO)
analysis of these proteins revealed an enrichment of molecular functions corresponding to
nucleotide binding (Fig. 4.1I). Taken together, our data demonstrate that the POLD3 interaction
network encompasses the DNA repair complexes Pol -REV1 and FANCD2-I, as well as an array
of other novel factors involved in diverse chromatin processes.
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IV. Identification of SPATA5L1, a novel POLD3-interacting ATPase
Spermatogenesis-associated protein 5-like protein 1 (SPATA5L1) is an uncharacterized
nucleotide binding protein that was enriched in FH-POLD3 purification samples (Fig. 4.2A, B).
Based on structure, it is predicted to contain two ATPase domains and to be a member of the
AAA+ protein family involved in diverse cellular processes including DNA replication, repair, and
protein degradation (Snider et al., 2008). Given the unknown nature of this protein, we started
with a basic characterization of its expression and localization in cells. By Western blot,
endogenous SPATA5L1 was expressed across a broad range of cell lines, including primary
fibroblast IMR-90, non-transformed MCF 10A, and numerous transformed and cancer-derived
lines (Fig. 4.2C). Exogenous expression of FH-SPATA5L1 and cell fractionation confirmed the
correct protein band and its presence in the nucleus (Fig. 4.2C, D). Reciprocal CoIPs were used
to validate the interaction between POLD3 and SPATA5L1. Consistent with the mass spec, the
interaction was independent of DNA damage and required the N-terminal POLD2-interacting
domain of POLD3 (1-144), suggesting it may be indirect (Fig. 4.2E). Notably, the interaction was
maintained in G2 and mitosis, when POLD3-dependent repair processes are active (Fig. 4.2F).
The interaction of SPATA5L1 with POLD3 predicts the presence of this protein at
replication forks and damage sites that contain abundant POLD3. By microscopy, SPATA5L1
could be visualized at a subset of damaged replication forks following prolonged hydroxyurea
(HU) treatment (Fig. 4.3A). By isolating proteins on nascent DNA (iPOND), SPATA5L1 was
associated with untreated and HU-stalled replication forks (Fig. 4.3B). However, unlike POLD3
and PCNA which mainly function at replication forks, SPATA5L1 association with nascent DNA
did not decrease after a thymidine pulse (Fig. 4.3B). This suggests that while SPATA5L1
interacts with POLD3 at sites of replication, it is not specific to replication forks and likely has a
broader chromatin function. Since telomere damage using TRF1-FokI generates easily
observable foci and POLD3-dependent repair synthesis, we examined SPATA5L1 localization in
this setting. Strikingly, SPATA5L1 colocalized with a subset of ALT telomeres at baseline and this
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was significantly increased after TRF1-FokI induction for 2 h (Fig. 4.3C, D). Taken together, we
have identified SPATA5L1 as a novel POLD3-interacting protein. Our data establish that
SPATA5L1 is a broadly expressed chromatin-associated protein that localizes to replication forks
and damaged telomeres.

V. SPATA5L1 is required for viability and genome stability
To determine the functional relevance of SPATA5L1, we disrupted its expression using
CRISPR guides (sgSPATA5L1) targeting the first exon and the ATPase domains (Fig. 4.4A, B).
Surprisingly, we could not maintain stable cell lines with complete disruption of SPATA5L1.
Clonogenic experiments confirmed a dramatic reduction in viability of sgSPATA5L1 cells
compared to sgEmpty controls (Fig. 4.4C). This effect was consistent across multiple sgRNAs,
cell lines, and regardless of the day cells were seeded after sgRNA transduction (Fig. 4.4D, E). In
accordance with reduced viability, MCF 10A exhibited a gradual reduction in EdU incorporation
and S-phase percentage after sgSPATA5L1 (Fig 4.S2A-C). While the average nuclear size of
these populations increased, the G1/G2 ratio was largely unchanged (Fig. 4.S2D, E).
Since SPATA5L1 interacts with chromatin and localizes to replication forks and
telomeres, we assessed its contribution to genome stability. Loss of SPATA5L1 resulted in a
marked increase in micronuclei across multiple sgRNAs and cell lines, indicating emergent
genome instability (Fig. 4.5A-C). C-circles, which are a marker of telomere damage in ALT cells,
were also elevated after sgSPATA5L1, suggesting a perturbation of replication or repair at this
genomic region (Fig. 4.5D, E). Taken together, our data outline an essential role for SPATA5L1 in
promoting cell viability and genome stability broadly, including at the telomere.
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VI. Discussion
POLD3 is an essential member of Pol  that facilitates a diverse set of replication and
repair processes utilized by normal and cancer cells. By purifying POLD3, we have provided an
unbiased characterization of its protein interactions. Top enriched factors included the Pol REV1 and FANCD2-I complexes. In support of our data, POLD3 was previously shown to be a
member of Pol  and to interact with REV1 (Baranovskiy et al., 2012; Johnson et al., 2012; Kim et
al., 2013; Makarova et al., 2012; Pustovalova et al., 2016). However, there are no reports of
FANCD2-I interacting with POLD3 or Pol . It will be important to determine if this interaction is
through Pol  or alternatively through PCNA or Pol -REV1 (Budzowska et al., 2015; Howlett et
al., 2009). FANCD2-I and Pol -REV1 both have key functions in the FA pathway (Ceccaldi et al.,
2016). The convergence of these proteins on POLD3 raises the possibility that in addition to
functioning in the FA pathway, they may play a coordinated role in regulating Pol -dependent
repair processes. This should be considered in light of recently described roles of FANCD2 and
POLD3 in repair of damaged replication forks and ALT telomere synthesis (see Chapter 3) (Dilley
et al., 2016; Fan et al., 2009; Minocherhomji et al., 2015; Root et al., 2016; Roumelioti et al.,
2016).
POLD3 purification revealed an abundance of putative novel protein interactions. We
focused on the interaction with SPATA5L1, a previously uncharacterized AAA+ family ATPase.
SPATA5L1 was expressed in the nucleus of a broad range of cell lines and interacted with
POLD3 throughout the cell cycle. Consistent with its POLD3 interaction, SPATA5L1 localized to
replication forks and damaged telomeres, both sites of abundant POLD3. However, SPATA5L1
was not specifically associated with progressing replication forks. We suggest that it likely
functions more broadly on chromatin, with a subset of its activity converging with POLD3dependent processes. Although the mechanism of SPATA5L1 is unknown, it was required for cell
viability and genome stability, proving an essential role for this protein and suggesting a
connection to DNA replication and/or repair. Current studies are focused on addressing the
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following questions: 1) What are the major binding partners of SPATA5L1? 2) What is the role of
the SPATA5L1 ATPase domains? 3) Why does SPATA5L1 loss result in decreased viability? 4)
How does SPATA5L1 loss affect POLD3-dependent processes? While the AAA+ family proteins
have diverse functions, protein homology provides potential clues. SPATA5 and p97/VCP share
the most homology with SPATA5L1, with 30-40% sequence similarity. While SPATA5 is thought
to function in the mitochondria, p97/VCP is a segregase that extracts proteins from chromatin
thereby regulating DNA replication and repair (Liu et al., 2000; Vaz et al., 2013). Recent studies
have highlighted how removal of proteins from chromatin facilitates repair of replicative lesions
and DNA-protein crosslinks (Kottemann et al., 2018; Stingele et al., 2017). Interestingly,
mutations in p97/VCP have been linked to several human diseases including neurodegeneration.
It will be important to determine if SPATA5L1 performs similar functions as p97/VCP, particularly
with respect to POLD3. Other possible AAA functions include DNA clamp loader and helicase
activity, as exemplified by the RFC and MCM complexes respectively (Snider et al., 2008).
Variants in SPATA5L1 have been linked to chronic kidney disease using genome-wide
association studies (Köttgen et al., 2009; Kubo et al., 2017; Park et al., 2013). In light of its role in
genome stability, a reevaluation of the contribution of SPATA5L1 to human disease may be
warranted. In summary, by purifying POLD3 we have uncovered an unexpected role for
SPATA5L1 in cell viability and genome stability. The complex interaction network of POLD3
engages an abundance of proteins potentially important for regulating replication and repair.

VII. Materials and Methods
Methods from Chapters 2 and 3 are not described again here. Please refer to those sections for
details.

Plasmids and CRISPR sgRNAs
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Expression vectors were generated by cloning the following cDNA sequences into the pOZ–N–
Flag–HA retroviral vector:
POLD3: RefSeq NM_006591.2
PCNA: RefSeq NM_002592.2
SPATA5L1: RefSeq NM_024063.2
The following forward sgRNA sequences were cloned into plentiGuide-Puro:
sgSPATA5L1: #1 5’-CACCGGCCCCGGTCTCTAGCGTCTA-3’, #2 5’CACCGCCCTTAGACGCTAGAGACCG-3’, #3 5’-CACCGGTGTGCGATGGCTCCGGACT-3’, #4
5’-CACCGCTGGGTCTTGCCCACTCCGG-3’, #5 5’-CACCGAGAGTGGTTTTAGCACATCC-3’
All experiments other than clonogenics were analyzed between 9-12 days post sgRNA virus
transduction.

Antibodies
The following antibodies were used: anti-BrdU (mouse B44, BD 347580), anti-POLD3 (mouse
3E2, Abnova H00010714-M01), anti-PCNA (mouse PC10, CST #2586) anti-GAPDH (rabbit
14c10, CST #2118), anti-αTubulin (mouse TU-02, Santa Cruz sc-8035), anti-pKAP1 S824 (rabbit,
Bethyl A300-767A), anti-pPLK1 T210 (rabbit, CST #5472), anti-FANCD2 (mouse FI17, Santa
Cruz sc-20022), anti-POLD1 (mouse 607, Abcam ab10362), anti-POLD2 (rabbit, Bethyl A304322A), anti-REV7 (rabbit, Invitrogen PA5-49352), anti-HA (rabbit C29F4, CST #3724), anti-TRF2
(mouse 4A794.15, Invitrogen MA1-41001), anti-SPATA5L1 (rabbit, Novus NBP1-92430).

FLAG-HA tandem purification
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Tandem affinity purifications were performed according to the standard protocol (Nakatani and
Ogryzko, 2003). Briefly, nuclei were isolated from ~3L of HeLa S3 suspension cells. Nuclei were
lysed in high salt KETNG-400 and subsequently dialyzed in KETNG-150. FLAG and HA IP were
performed using anti-FLAG M2 Affinity Gel (Sigma) and EZview Red Anti-HA Affinity Gel (Sigma)
respectively. A portion of the final purified material was electrophoresed in a 4%–12% bis-tris
SDS gel for silver staining. The remaining purified product was TCA precipitated and analyzed by
tandem mass spectrometry at the Harvard Medical School Taplin Biological Mass Spectrometry
facility.

Co-immunoprecipitation
Whole cells were lysed in NETN-150. Lysates were subsequently incubated with anti-FLAG M2
Affinity Gel (Sigma) for 3-4 h at 4 °C. Beads were washed 4x with NETN-150 and samples eluted
with 0.2mg/ml FLAG peptide in NETN-150 for 1 h at 4 °C.

Isolation of proteins on nascent DNA (iPOND)
iPOND was performed according to published protocols (Kottemann et al., 2018; Sirbu et al.,
2012).

Clonogenic assay
At 4-9 days post sgRNA virus transduction, cells were trypsinized, counted, and 300-500 cells
plated on 6-well plates in triplicate. After 10-14 days, plates were washed with PBS and stained
with crystal violet solution.
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Figure 4.1. Purification of the POLD3-replisome.
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(A-B) Schematic of tagged replisome components (A), with western blot of stable HeLa S3 lines
T1FI induction for 2 h (B).
(C) Silver stain of tandem purified samples from HeLa S3 lines T1FI induction for 2 h. Bait
proteins and stoichiometric binding partners noted in red.
(D) Table of unique and total peptides corresponding to bait proteins and major complex
members identified from mass spectrometry of TCA precipitated purified samples.
(E) Graphical representation of proteins unique to POLD3 samples (not seen in PCNA samples),
ranked according to abundance. Top 2 proteins (FANCI and REV3L) and known binding partners
(FANCD2 and REV1) noted in green.
(F, G) CoIP western blot validation of POLD3 binding partners in asn and mitosis arrested HeLa
S3 (F), and 293T transiently expressing FH-POLD3 deletion mutants (G).
(H, I) Venn diagram of proteins unique to POLD3 samples with 2 unique peptides (H), and table
of top 5 GO molecular function classes of the 222 shared proteins (I).
IP, immunoprecipitation; WCE, whole cell extract; EV, empty vector; FH, FLAG-HA tag; T1FI,
TRF1-FokI; Asn, asynchronous.
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Figure 4.2. Identification of SPATA5L1, an uncharacterized POLD3-interacting protein.
(A) Schematic of SPATA5L1 protein domain structure.
(B) Table of unique and total peptides corresponding to SPATA5L1 identified from mass
spectrometry of TCA precipitated purified samples.
(C, D) Western blots of a panel of endogenous and FH-SPATA5L1 overexpressing lines (C), and
HeLa S3 cell fractionation (D). Arrow indicates band corresponding to SPATA5L1.
(E, F) Reciprocal CoIP western blots of FH-POLD3 constructs T1FI induction for 2 h (E) and FHSPATA5L1 in different cell cycle phases (F).
IP, immunoprecipitation; WCE, whole cell extract; T1FI, TRF1-FokI; Asn, asynchronous; Noc SO,
nocodazole shakeoff.

Figure 4.3. SPATA5L1 localizes to replication forks and damaged telomeres.
(A) Representative image of HA-SPATA5L1-H2AX colocalization in FH-SPATA5L1 U-2 OS line
treated with HU for 24 h.
(B) iPOND western blot of FH-SPATA5L1 HeLa S3 line EdU 20 min Thy chase for 1 h or HU
treatment for 4 h. Histones shown by Ponceau stain.
(C, D) Representative images of HA-SPATA5L1-telomere/T1FI colocalizations in FH-SPATA5L1
U-2 OS line T1FI induction for 2 h (C), with quantification (D).
FH, FLAG-HA tag; EdU, 5-Ethynyl-2'-deoxyuridine; Thy, thymidine; HU, hydroxyurea; T1FI,
TRF1-FokI. Data represent mean ± s.e.m. of representative experiment done in triplicate.
***P ≤ 0.001.
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Figure 4.4. SPATA5L1 is essential for viability.
(A, B) Schematic of SPATA5L1 domains targeted by CRISPR guides (sgSPATA5L1) (A), with
western blot of sgSPATA5L1 populations compared to empty guide control (sgEmpty) (B). Arrow
indicates band corresponding to SPATA5L1.
(C-E) Representative image of clonogenic plates from cells expressing sgSPATA5L1 compared
to sgEmpty (C), with quantifications (D, E).
Data represent mean ± s.e.m. of representative experiments done in triplicate. ****P ≤ 0.0001.
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Figure 4.5. Disruption of SPATA5L1 results in genome instability.
(A-C) Representative image of micronuclei from cells expressing sgSPATA5L1 compared to
sgEmpty (A), with quantifications (B, C).
(D, E) C-circle dot blot from U-2 OS expressing sgSPATA5L1 compared to sgEmpty (D) with
quantification (E).
Data represent mean ± s.e.m. of representative experiments done in triplicate. ****P ≤ 0.0001,
***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05.
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Figure 4.S1. Extended analysis of POLD3 purification.
(A, B) Silver stain of tandem purified samples and flow-through from HeLa S3 lines (A), with
western blot for bait proteins (B).
(C, D) Tables of unique and total peptides corresponding to top binding partners identified from
mass spectrometry of TCA precipitated purified samples (C), with repeat experiment (D).
(E, F) CoIP western blots of FH-POLD3 expressing HeLa S3 treated with damaging agents (E)
and U-2 OS (F).
FT, flow-through; Gly, glycine; IP, immunoprecipitation; WCE, whole cell extract; EV, empty
vector; FH, FLAG-HA tag; T1FI, TRF1-FokI; HU, hydroxyurea; Etop, etoposide.
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Figure 4.S2. Disruption of SPATA5L1 affects cell cycle progression.
(A-C) Representative image of EdU incorporation from MCF 10A expressing sgSPATA5L1
compared to sgEmpty (A), with quantification (B) and timecourse (C).
(D) Quantification of nuclear particle size from MCF 10A expressing sgSPATA5L1 compared to
sgEmpty.
(E) Propidium iodide cell cycle profile from MCF 10A pool expressing sgSPATA5L1 compared to
sgEmpty. Green, G1; yellow, S; blue, G2/M.
Data represent mean ± s.e.m. of representative experiments done in triplicate.
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CHAPTER 5: DISCUSSION AND FUTURE DIRECTIONS

I. Summary
The primary aim of this thesis was to investigate the mechanisms of mammalian DNA
repair synthesis by using alternative lengthening of telomeres (ALT) as a model system.
Specifically, we started by addressing 4 fundamental questions: 1) Can ALT telomere synthesis
be monitored directly? 2) Does synthesis depend on RAD51 homology searches? 3) What are
the replisome components that contribute to this synthesis? 4) Is telomere repair synthesis
important for ALT telomere maintenance? By developing novel tools to answer these questions,
we discovered a central role for POLD3 in telomere repair synthesis and ALT, providing the first
study of mammalian break-induced DNA repair synthesis at a defined genomic location (Dilley et
al., 2016). These initial findings also generated a framework to explore other relevant questions,
including the molecular regulation of this telomere repair synthesis and the composition of the
POLD3 replication complex.
In Chapter 2, we addressed the aforementioned questions in order to characterize
telomere repair synthesis during ALT. To accomplish this, we utilized the TRF1-FokI system
which induces ALT activity though the generation of telomere DSBs (Cho et al., 2014) in
conjunction with novel assays to directly monitor telomere synthesis. By doing so, we found that
telomere double strand breaks (DSBs) elicited robust templated synthesis capable of generating
long nascent telomeres. This telomere repair synthesis, which we named break-induced telomere
synthesis (BITS), occurred by an alternative form of homology-directed repair (HDR) independent
of RAD51. Additionally, BITS required POLD3/Pol  and PCNA, which were rapidly recruited to
damaged telomeres, but was independent of many other members of the S-phase replication
complex. While we observed that BITS could be generated in both ALT-positive and telomerasepositive cells, spontaneous telomere repair synthesis was restricted to ALT cells and had the
same molecular requirements as BITS. Finally, overall telomere maintenance was disrupted in
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POLD3 deficient ALT cells, supporting an essential role for POLD3-dependent telomere repair
synthesis in ALT.
In Chapter 3 we explored the regulation of telomere repair synthesis in ALT. Through
interrogation of BITS functionality in mitosis, a time when much of DSB repair is repressed, we
validated that BITS proceeds through alternative HDR independent of RAD51. Furthermore, by
using mitosis as a window into alternative proteins that could coordinate telomere repair
synthesis, we identified RAD52, which was recruited to damaged ALT telomeres likely to resolve
replication stress. Depletion of RAD52 reduced spontaneous telomere repair synthesis, whereas
BITS was unaffected, suggesting a potential role downstream of replicative lesions, but not DSBs.
In line with multiple repair pathways responding to distinct types of telomere damage, RAD52 was
responsible for a subset of telomere maintenance but did not affect the survival of ALT cells.
Finally, RAD52 deficient ALT cells were hypersensitive to the loss of the nuclease scaffold SLX4.
In Chapter 4 we examined the composition of the POLD3 replication complex. Utilizing
protein purification and mass spectrometry analysis, we confirmed major interactions with the
core Pol  members as well as many less abundant interactions, including with Pol -REV1 and
FANCD2-I. Surprisingly, we identified a novel interaction with SPATA5L1, an uncharacterized
AAA family ATPase. SPATA5L1 localized to chromatin, replication forks, and damaged ALT
telomeres. Strikingly, SPATA5L1 was essential for cell viability and genome stability across a
range of cell lines, suggesting a fundamental role for this protein. This proteomic analysis of
POLD3 uncovered many putative novel interactions that could prove important for the regulation
of POLD3-dependent replication and repair processes.
The subsequent sections outline current models and how our findings fit into the broader
context of the field, as well as future directions of study.
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II. Mechanisms of telomere repair synthesis and ALT
At the outset of this thesis work, the mechanisms of mammalian HDR synthesis were
largely unknown. To address fundamental questions concerning these processes, we focused on
using ALT as a model system. Prior to our work, models of human ALT were largely formulated
based on yeast telomerase negative survivors which utilize BIR pathways to maintain their
telomeres (Cesare and Reddel, 2010; McEachern and Haber, 2006). A key early study of human
ALT revealed copying of a telomere tag to other chromosome ends, proving that ALT proceeds
through HDR (Dunham et al., 2000). Additionally, ALT telomeres were shown to colocalize with
numerous DNA repair factors within APBs and rely on the MRN complex for maintenance
(Yeager et al., 1999; Zhong et al., 2007). A major breakthrough came when a study from our lab
demonstrated that telomere-targeted DSBs using the TRF1-FokI fusion protein directly resulted in
an induction of ALT activity (Cho et al., 2014). By harnessing this system and developing novel
techniques to directly monitor telomere synthesis, we discovered a central role for POLD3 in
telomere repair synthesis and ALT (Dilley et al., 2016). Since the publication of our study, several
other groups have also demonstrated a similar role for POLD3 in ALT (Garcia-Exposito et al.,
2016; Roumelioti et al., 2016; Sobinoff et al., 2017).
As previously mentioned, ALT was hypothesized to proceed through BIR pathways
analogous to those described in yeast. Much of our data is consistent with this idea, however
there are also some notable differences as described below. Since mammalian BIR pathways are
poorly defined and unlikely to be completely identical to those in yeast, we have avoided using
the term BIR to describe our findings and instead prefer BITS, or BIR-like. Similar to yeast BIR,
BITS can be initiated by DSBs and can produce very long nascent tracks, up to 70kb, that
required POLD3 and PCNA. Another group showed that ALT telomere synthesis also results in
conservative inheritance of nascent DNA, similar to yeast BIR (Roumelioti et al., 2016). However,
BITS did not require other canonical S-phase replication components such as Pol , Pol , or
MCM2-7, which have all been implicated in yeast BIR. These differences could be due to
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genomic location (i.e. telomere vs. internal site), or divergence of mechanisms during evolution.
Notably, the approaches we have used identify large scale changes in DNA synthesis, in which
POLD3/Pol  had a significant effect, consistent with its central role in yeast (Lydeard et al., 2007;
Prindle and Loeb, 2012). It remains to be seen whether these other polymerases may be playing
a role that escaped our detection, as is likely the case for translesion (TLS) polymerases (GarciaExposito et al., 2016; Sakofsky et al., 2015).
In order to appreciate the broader context of POLD3-dependent telomere repair synthesis
within ALT, it is crucial to consider the upstream and downstream steps of this process.
Homology pairing is a fundamental step that must occur prior to templated DNA synthesis. As in
most HDR events, homology pairing during yeast BIR is typically, but not exclusively, carried out
by the Rad51 recombinase. Notably, there are two distinct subtypes of yeast telomerase negative
survivors: type I, which are Rad51-dependent, and type II, which are Rad51-independent
(McEachern and Haber, 2006). Our initial studies using TRF1-FokI defined a RAD51-dependent
pathway of long-range, interchromosomal homology searches in ALT cells (Cho et al., 2014).
However, BITS and spontaneous ALT telomere repair synthesis were independent of RAD51,
suggesting the existence of a minor RAD51-dependent pathway and a major RAD51-independent
pathway. While yeast type I survivors are more common, it was noted that type II survivors have
telomeres that more closely resemble those seen in human ALT (Teng and Zakian, 1999).
Mitosis is a phase of the cell cycle when most DSB repair, including RAD51-dependent
repair, is repressed (Hustedt and Durocher, 2016; Orthwein et al., 2014). This allowed us to
confirm that BITS was a non-canonical RAD51-independent process that escaped mitotic
inhibition. Additionally, we identified RAD52 as an important mediator of telomere repair
synthesis, consistent with recent reports of RAD52 involvement in mammalian BIR-like pathways
(Bhowmick et al., 2016; Min et al., 2017; Özer et al., 2018; Sotiriou et al., 2016). While RAD52
was recruited to ALT telomeres damaged by replication stress and DSBs, it was only required for
spontaneous telomere repair synthesis, not BITS. This suggests the existence of multiple
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pathways that respond to either replicative lesions or DSBs, ultimately feeding into POLD3dependent telomere synthesis. Our preliminary data suggest that conversion of replication
intermediates into DSBs through the action of nucleases (e.g. SLX4) may be a switch between
these pathways. Although Rad52 is responsible for all BIR and telomerase negative survivor
pathways in yeast, the story in mammalian cells is more complex and requires further
investigation. It is important to note that the generation of frank DSBs by TRF1-FokI may bypass
many of the endogenous mechanisms working in ALT cells. Therefore, conclusions should be
made based on the use of complementary assays for BITS and spontaneous telomere repair
synthesis.
While we have provided some of the first mechanistic details of telomere repair synthesis
in ALT, our work has raised many important questions that need to be addressed. The future
directions below are organized from predicted early to late events during ALT telomere repair. 1)
What are the endogenous sources of damage that engage telomere repair synthesis? It appears
that ALT can be activated by replication stress and DSBs. The relative contribution of these and
other pathways remains to be examined. 2) What are the upstream processing events that result
in loading of the replisome? MRN has been linked to ALT telomere maintenance but its role in
telomere repair synthesis is currently unknown (Zhong et al., 2007). Additionally, BLM has
recently been implicated in telomere repair synthesis and should be further examined (Sobinoff et
al., 2017). 3) What are the homology pairing mechanisms that promote synthesis? Our data
predict multiple sources of damage that can activate telomere repair synthesis. How do the
homology pairing mechanisms compare in these different scenarios? While RAD52 seems to
respond to replication stress, it is unclear whether it is mediating homology pairing. Additionally,
since RAD52 is not required for BITS, further studies into the factors mediating pairing after DSBs
are needed. 4) What are the substrates used for templated synthesis? Although the spectrum of
substrate usage is likely to be vast, the RAD51 independence of the majority of telomere repair
synthesis insinuates annealing to single stranded substrates. Enticing speculations include
intramolecular invasions or utilization of extrachromosomal elements such as C-circles (Henson
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et al., 2009). 5) What are the other replication components important for telomere repair
synthesis. Specifically, the role of other polymerases, such as TLS factors, and helicases should
be examined. Additionally, understanding how these factors are regulated to control recruitment,
execution, and coordination will be critical. 6) How are recombination intermediates resolved?
The alternative pathways of BLM dissolution vs. nuclease mediated resolution should be further
explored. 7) What is the impact of telomere repair synthesis and ALT activity on genome stability?
In addition to contributing to genome stability, HDR pathways, especially BIR and MMBIR, are
known to be mutagenic (Carvalho and Lupski, 2016; Malkova and Haber, 2012). The
mutagenicity of telomere repair synthesis and whether it leads to variant telomere sequences or
genomic rearrangements seen in ALT cells should be investigated (Conomos et al., 2012; Marzec
et al., 2015; Varley et al., 2002).
While much remains to be uncovered, the picture of ALT is becoming clearer. A simplistic
model is as follows. Telomeric chromatin changes and increased replication stress likely lead to a
diverse set of DNA lesions at ALT telomeres including stalled replication forks and DSBs. As a
result, multiple competing repair pathways are engaged, including RAD52 and RAD51, with
RAD52 controlling repair at a majority of endogenous lesions. The POLD3 replication complex is
then activated in order to perform the majority of telomere repair synthesis. ALT telomeres likely
accumulate damage during S-phase, leading to the stimulation of repair in late S/G2. This repair
synthesis can continue into mitosis since it is non-canonical, although our data suggest that this is
likely a minority of ALT activity and may depend on the integrity of the G2/M checkpoint
(Bhowmick et al., 2016; Min et al., 2017; Minocherhomji et al., 2015; Özer et al., 2018).
Consistent with recent reports, there are likely similar pathways utilized to repair replicative
lesions in other genomic regions, as discussed in the next section (Costantino et al., 2014;
Minocherhomji et al., 2015).
Ultimately, we propose that telomere repair synthesis is important not only for maintaining
the integrity of telomeres in ALT cells, but also for their elongation and ultimately cell survival.
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POLD3 appears to be critical for both phenotypes, although long-term effects of POLD3 loss are
difficult to assess since it is an essential protein (Murga et al., 2016). Elucidating the mechanistic
details of all the steps of telomere repair synthesis, including the contribution of putative factors to
synthesis, telomere maintenance, and viability will be essential to obtain a deeper understanding
of ALT and exploit potential therapeutic opportunities.

III. Roles of the POLD3-replication complex
Upon initiation of this thesis work, very little was known about the role of Pol  or any
other DNA polymerase in mammalian HDR. Studies in yeast linked Pol  activity not only to Sphase replication, but also to various forms of repair, including MMR, TLS, BER, NER, and HDR
(Prindle and Loeb, 2012). Notably, the accessory subunit Pol32 was required for yeast BIR and
telomerase negative survivors, but not gene conversion (GC) (Lydeard et al., 2007). Just prior to
the initiation of our project, a new study provided the first description of a mammalian BIR-like
process that depended on POLD3 (Costantino et al., 2014), the mammalian homolog of Pol32.
This was the first definitive cellular role for POLD3 in HDR, which up until that point had mainly
been studied in vitro and noted to localize to sites of replicative damage (Baranovskiy et al., 2008;
Chea et al., 2012; Ducoux et al., 2001; Hughes et al., 1999; Pohler et al., 2005). Our work
independently identified POLD3 as a vital factor executing telomere repair synthesis during ALT
(Dilley et al., 2016). During the course of our work and since its publication, numerous groups
have discovered roles for POLD3 in a diverse set of HDR processes, positioning POLD3 as a
critical node of DNA repair synthesis in the cell (Garcia-Exposito et al., 2016; Lemaçon et al.,
2017; Minocherhomji et al., 2015; Murga et al., 2016; Roumelioti et al., 2016; Sobinoff et al.,
2017; Tumini et al., 2016; Zhou et al., 2018).
In addition to providing important mechanistic insights into ALT, our work also
documents several key points pertinent to other studies on the POLD3 replication complex and its
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repair functions. First, we found that POLD3 and POLD4 control the stability of the entire human
Pol  complex, in accordance with another study in mice (Murga et al., 2016). As such, many
phenotypic effects of POLD3 depletion are likely due to a loss of the catalytic subunit POLD1.
While POLD3 may perform context specific functions, they are poorly understood. Additionally,
since Pol  performs many critical roles in replication and repair, long-term disruption of this
complex is expected to have extensive cellular consequences. This is exemplified by the
embryonic lethality of POLD3 deletion and haploinsufficiency for DNA replication in mice, largely
phenocopying the effects of POLD1 loss (Murga et al., 2016; Uchimura et al., 2009). Adding to
the complexity, POLD3 and POLD2 are also members of the Pol  TLS polymerase, which is
essential for embryonic development (Baranovskiy et al., 2012; Bemark et al., 2000; Johnson et
al., 2012; Makarova et al., 2012). It is currently unknown whether POLD3 controls the stability of
Pol  as it does for Pol , or whether Pol  could be responsible for some of the effects observed
upon POLD3 depletion. Through depletion of the catalytic subunits of Pol  (POLD1) and Pol 
(REV3L), we were able to determine that Pol  was the main polymerase responsible for telomere
repair synthesis and ALT. However, it is possible that Pol  is swapping with Pol  at difficult to
replicate sites, potentially providing a switch to more error prone mode of synthesis such as
MMBIR (Sakofsky et al., 2015). Future studies should address the regulation between Pol  and
Pol  and how this impacts HDR synthesis, including telomere repair synthesis and ALT.
An additional key point that emerged from our work concerns the recruitment of POLD3
to damage sites. Consistent with its known function (Ducoux et al., 2001), we found that POLD3
recruitment to telomere DSBs depended on its interaction with the clamp PCNA as well as the
clamp loader RFC1-5. Surprisingly, POLD3 and PCNA were recruited rapidly to these damage
sites, within 30 minutes, and prior to the accumulation of RAD51 and H2AX. Furthermore,
recruitment was independent of many early damage sensors including ATM, ATR, and MRE11.
These findings suggest POLD3 is part of an early damage sensing pathway at telomere DSBs. In
support of this idea, a recent study catalogued the protein dynamics at complex DNA lesions and
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found that RFC1-5, PCNA, and Pol  localized to damage sites at early timepoints (Aleksandrov
et al., 2018). The regulators of this early recruitment as well as its impact on repair remain to be
seen. Recent studies have reported roles for RAD52 and MUS81 mediated recruitment of POLD3
to damaged replication forks, and BLM mediated recruitment to ALT telomeres (Bhowmick et al.,
2016; Lemaçon et al., 2017; Minocherhomji et al., 2015; Sobinoff et al., 2017). Future studies are
needed to determine the full spectrum of the mechanisms and timing of POLD3 recruitment to
different types of DNA lesions.
Since it is clear that POLD3 is a nexus of many DNA replication and repair processes in
the cell, we hypothesized that its protein interactions would provide a resource to interrogate two
fundamental questions: 1) How is the POLD3 complex regulated to control timely localization,
execution, and coordination with the multitude of other chromatin processes? 2) What other
factors are important for POLD3-dependent replication and repair processes? Using protein
purification and mass spectrometry, we uncovered many novel putative interactions with the
POLD3 replication complex. As expected, POLD3 mainly interacted with POLD1 and POLD2, but
also with Pol -REV1, and FANCD2-I. An interaction with FANCD2-I has not been previously
reported. The biochemical details of this interaction as well as its potential impact on Pol dependent repair processes should be determined. Unexpectedly, we discovered a novel
interaction with SPATA5L1, an uncharacterized AAA ATPase. SPATA5L1 localized to chromatin,
replication forks, and damaged telomeres and was essential for viability and genome stability,
defining a crucial role for this new protein. Our current efforts are focused on determining the
mechanism of SPATA5L1 and its role in POLD3-dependent processes. Based on known AAA
functions, possibilities include protein extraction from chromatin, proteasome function, clamp
loading, and helicase activity, all of which are essential for coordinating DNA replication and
repair (Snider et al., 2008; Vaz et al., 2013). Continued studies of POLD3 interactions are
expected to yield a broad range of insights concerning DNA replication and repair synthesis.
Specifically, studies should define how these interactions are regulated and/or how the

93

interactions themselves might regulate POLD3. Ultimately, a spatiotemporal map of POLD3
subcomplexes will be required to better understand its activity in diverse contexts across the
genome and in response to various stimuli.
Other important questions to address include: 1) What is the role of post-translational
modifications (PTMs) of POLD3/Pol /Pol  in regulating their activity? Interestingly, several PTM
sites on POLD3 have been identified, including increased SUMOylation after replication stress
(Bursomanno et al., 2015; Lemmens et al., 2008; Liu and Warbrick, 2006). The effect of these
PTMs on POLD3 dependent HDR synthesis should be interrogated. Additionally, proteomic
analysis of Pol /Pol  in the context of different types of DNA damage may reveal additional
PTMs. 2) What is the mutagenicity of POLD3-dependent synthesis during different repair
processes. Although originally considered error free, it is increasingly becoming appreciated that
certain HDR pathways, such as BIR, are mutagenic and can promote genome instability (Deem
et al., 2011; Malkova and Haber, 2012; Sakofsky et al., 2014; Smith et al., 2007). A particularly
striking example is MMBIR which is thought to generate copy number variations and complex
chromosomal rearrangements through template switching (Carvalho and Lupski, 2016). Pol32
and Pol  promote MMBIR in yeast (Payen et al., 2008; Sakofsky et al., 2015), and whether
analogous roles are fulfilled by the mammalian homologs remains a crucial question. As a
starting point, the rate of mutations and chromosomal rearrangements during POLD3-dependent
repair of replication forks and telomeres should be determined. Subsequently, the potential roles
of TLS and MMR factors, as well as the consequences for genome stability and cell viability can
be addressed. 3) What is the role of POLD3 in human disease? It is clear that POLD3 plays an
essential role in many processes essential for normal and cancer cell viability. However, whether
these processes are directly subverted or differentially regulated in human diseases remains
poorly understood. For example, are these repair pathways upregulated or downregulated in
human cancer? ALT is a clear example of gain of repair function at the telomere that facilitates
cancer cell survival. The existence of analogous perturbations should be assessed more broadly.
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Interestingly, POLD1 exonuclease mutations and variants near POLD3 are implicated in
colorectal cancer (Dunlop et al., 2012; Palles et al., 2013). With more publicly available datasets
and enhanced sequencing technology, questions of altered expression and mutations should be
revisited.
In the past four years, we have seen the emergence of studies providing the first insights
into the mechanisms of mammalian HDR synthesis, with POLD3 being a central component. Our
work was among these first descriptions in which we discovered a crucial role for POLD3 in
telomere repair synthesis and ALT. By purifying the POLD3 replication complex we are
uncovering a vast network of interactions predicted to impact replication and repair processes.
Continued studies are needed to expose and interpret the molecular and cellular details of these
POLD3-dependent processes and how they intersect with other repair pathways and chromatin
activities.

IV. Concluding remarks
In conclusion, the work presented in this thesis successfully addressed several of the
initially proposed aims. Specifically, we developed novel approaches to provide the first
documentation of mammalian HDR synthesis at a defined locus. Through these studies, we
discovered POLD3 to be a central mediator of telomere repair synthesis, which ultimately
underlies ALT (Dilley et al., 2016). Much of our work has been validated by other studies at
replication forks and ALT telomeres (Costantino et al., 2014; Garcia-Exposito et al., 2016;
Lemaçon et al., 2017; Minocherhomji et al., 2015; Murga et al., 2016; Roumelioti et al., 2016;
Sobinoff et al., 2017; Tumini et al., 2016; Zhou et al., 2018). Therefore, we propose that there is
an overlapping network of POLD3-dependent replication and repair processes capable of
executing DNA synthesis in response to a wide variety of stimuli. As we have likely only
uncovered the tip of the proverbial iceberg, future studies are needed to dissect the details of
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these repair processes. Our continued work on this topic revealed a role for RAD52 in controlling
spontaneous telomere repair synthesis in ALT cells. Finally, through purification of the POLD3
replication complex we uncovered new interactions with known as well as uncharacterized
proteins. Taken together, this thesis provides novel mechanistic insights and a framework for
continued studies of mammalian DNA repair synthesis.
Our understanding of the DDR and genome maintenance has come a long way since the
pioneering work of Boveri, Muller, and McClintock in the early 20th century (Boveri, 2008; Ciccia
and Elledge, 2010; Jeggo et al., 2016; McClintock, 1938; Muller, 1927; 1928). Key breakthroughs
are often born out of paradigm shifting studies and new technological advances, as occurred
subsequent to solving the structure of DNA (Franklin and Gosling, 1953; Watson and Crick,
1953). We are now participating in an exciting era of biomedical science where the development
of new technologies is outpacing their application. We should attempt to incorporate these new
technologies, including CRISPR/Cas9, live-cell and single-molecule imaging, next-generation
sequencing, and other omics approaches into our experimental arsenal and apply them to studies
of the DDR and genome maintenance (Doudna and Charpentier, 2014; Goodwin et al., 2016;
Hasin et al., 2017; Hsu et al., 2014; Liu et al., 2015). Additionally, the availability of large-scale
experimental and human datasets should be mined judiciously. While these technologies will
undoubtedly facilitate new discoveries, it is important to not lose sight of the fundamental
questions that remain unsolved and to revisit old ideas in a new light. I hope that the work
presented in this thesis will prove useful for future studies on the subjects of DNA synthesis and
repair, telomere maintenance, and cancer biology.
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